Postural Orthostatic Tachycardia Syndrome
Open accessAbstract
Postural orthostatic tachycardia syndrome (POTS), the most common form of orthostatic intolerance in young people, affects approximately 500,000 people in the United States alone, typically young women at the peak of their education and the beginning of their working lives. This is a heterogeneous disorder, the pathophysiology and mechanisms of which are not well understood. There are multiple contributing factors and numerous potential mimics. This review details the most current views on the potential causes, comorbid conditions, proposed subtypes, differential diagnoses, evaluations, and treatment of POTS from cardiological and neurological perspectives.
AI snapshot
Written from the paper’s full text.
TL;DR
POTS is a heterogeneous syndrome of orthostatic intolerance, most common in young people, defined by a standing heart rate increment of ≥30 bpm (≥40 bpm in ages 12–19) without orthostatic hypotension, accompanied by symptoms. This review synthesizes proposed mechanisms, subtypes, differential diagnosis, evaluation, and management, emphasizing cardiovascular deconditioning and exercise-based reconditioning as central.
Key findings
- POTS has a reported prevalence of 0.2%, affecting an estimated 500,000 Americans based on a 1999 report; the typical demographic is young women (mean age 30.2 ± 10.3 years, 86% women) with an average supine-to-upright heart rate increment of 44.2 ± 13.2 beats/min.
- Onset can be subacute (13.8%), insidious (5.9%), or acute (12.5%), and is frequently preceded by a viral illness (42%) or occurs post-operatively (9.5%).
- Cardiovascular deconditioning appears universally present: reduced cardiac size/mass by 16%, reduced blood volume by 20%, reduced stroke volume, and reduced peak oxygen uptake versus matched sedentary controls; a 3-month progressive exercise program leads to improvement or remission in the majority and was superior to propranolol for restoring upright hemodynamics and quality of life.
- Proposed subtypes include neuropathic, hyperadrenergic (30%–60% of patients; standing norepinephrine >600 pg/ml), volume dysregulation (approximately 30% with <100 mEq 24-h urinary sodium), mast cell activation disorder, and autoimmunity; in one study, >50% of POTS patients had loss of distal lower-extremity sweat function.
Methods
- Narrative review (JACC Focus Seminar); no primary cohort, systematic search, or meta-analysis is described.
- Synthesizes prior literature and consensus statements (2011 and 2015) on pathophysiology, proposed subtypes, differential diagnosis, evaluation, and treatment.
- Main analysis is qualitative synthesis; no new statistical analysis is reported.
Limitations
- Stated: pathophysiology and mechanisms are not well understood; the disorder is heterogeneous; proposed subtypes are not mutually exclusive or clearly independent; autoantibody associations have not been convincingly proven pathophysiologically or diagnostically; the role of mast cell activation is controversial; no medication is FDA approved for POTS, and clinical trials supporting efficacy are absent.
- Evident: as a narrative review, it lacks systematic search/selection criteria and relies on cited studies of varying designs, including small and retrospective studies; some cited findings have not been reproduced (e.g., the significance of nondipping is unclear).
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
64 of 148 cited sources checked · 31 supported · 1 flagged · accuracy not yet measured
- Premisecitation
Direct testing of autonomic function in POTS patients is often normal or appropriate for the hemodynamic stress.
“direct testing of autonomic function in this patient population is often normal/appropriate for the hemodynamic stress (4).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [4] Fu, 2010, Cardiac origins of the postural orthostatic tachycardia syndrome, J Am Coll Cardiol source
- Premisecitation
The pathophysiological mechanisms underlying POTS are thought to be heterogeneous.
“The pathophysiological mechanisms underlying POTS are thought to be heterogeneous (15).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [15] Benarroch, 2012, Postural tachycardia syndrome: a heterogeneous and multifactorial disorder, Mayo Clin Proc source
- Premisecitation
In patients under 20 years of age, the HR increment with upright posture should exceed 40 beats/min to be considered clinically significant.
“in patients under 20 years of age, the HR increment with upright posture should exceed 40 beats/min in order to be considered clinically significant (1,3).”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [1] Sheldon, 2015, 2015 Heart Rhythm Society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope, Heart Rhythm source
The POTS Definition (Section 1; page not provided) gives a heart-rate increase of ≥40 beats/min on standing for individuals aged 12–19. The claim broadens that age range to everyone under 20 and says the increase must exceed 40, whereas the source includes exactly 40. It also presents the threshold as a general measure of clinical significance rather than one criterion of POTS. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [3] Freeman, 2011, Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome, Auton Neurosci source
- Premisecitation
There is a tight relationship between stroke volume and HR in men, healthy women, and women with POTS.
“Figure 2B shows the tight relationship between stroke volume and HR in men, healthy women, and women with POTS (4,12).”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [4] Fu, 2010, Cardiac origins of the postural orthostatic tachycardia syndrome, J Am Coll Cardiol source
The Discussion (page not provided) links smaller stroke volume to higher heart rate in POTS patients and describes a similar mechanism in young women. It does not establish a tight stroke-volume–heart-rate relationship across all three groups. The Methods (page not provided) report only one healthy male control, so the claim about men is not supported by this study. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites [12] Fu, 2009, Menstrual cycle effects on sympathetic neural responses to upright tilt, J Physiol source
The ‘Responses during upright tilt’ section reports that heart rate increased while stroke volume decreased in healthy men and women. It does not establish a tight stroke-volume–heart-rate relationship, and the ‘Study limitations’ section says all subjects were healthy, so the claim about women with POTS is not supported by this paper. (LLM, conf=0.82)
Experimental — accuracy not yet measured
- Premisecitation
Postflight orthostatic intolerance on return to Earth has been noted following both short- and long-term flights, especially in women astronauts.
“Since the inception of space missions, a postflight orthostatic intolerance on return to Earth has been noted following both short-and long-term flights, especially in women astronauts.”
Quote in the paperNot a substantial claim1 of 3 sources checked- cites [16] Fritsch-Yelle, 1996, Subnormal norepinephrine release relates to presyncope in astronauts after spaceflight, J Appl Physiol (1985) source
- cites [17] Buckey, 1996, Orthostatic intolerance after spaceflight, J Appl Physiol (1985) source
- cites [18] Levine, 2002, Human muscle sympathetic neural and haemodynamic responses to tilt following spaceflight, J Physiol source
The Discussion states that orthostatic intolerance has been observed after both short- and long-duration missions since the inception of the manned space program. It does not say it occurs especially in women; the Methods (Subjects) report that this study included only six male crew members. No page number is available for these passages. (LLM, conf=0.90)
Experimental — accuracy not yet measured
- Premisecitation
One feature that appears to be universally present in all POTS is cardiovascular deconditioning, characterized by cardiac atrophy and hypovolemia.
“One feature that appears to be universally present in all POTS is cardiovascular deconditioning, a specific biological process characterized by cardiac atrophy and hypovolemia (4).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [4] Fu, 2010, Cardiac origins of the postural orthostatic tachycardia syndrome, J Am Coll Cardiol source
The Discussion reports smaller left ventricular mass and lower blood volume in the patients studied, and describes deconditioning in terms of cardiac atrophy and hypovolemia. It does not establish that deconditioning is universally present in all people with POTS; the Discussion instead says that almost all of its patients had a history of physical inactivity and notes that POTS may have heterogeneous mechanisms. Page numbers are unavailable in our copy. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Premisecitation
Even after brief space trips, approximately one-fourth to two-thirds of astronauts cannot stand for even 10 min upon return to Earth.
“Even after brief trips, approximately one-fourth to two-thirds of astronauts cannot stand for even 10 min upon return to earth (16)(17)(18).”
Quote in the paperNot a substantial claim1 of 3 sources checked- cites [16] Fritsch-Yelle, 1996, Subnormal norepinephrine release relates to presyncope in astronauts after spaceflight, J Appl Physiol (1985) source
- cites [17] Buckey, 1996, Orthostatic intolerance after spaceflight, J Appl Physiol (1985) source
- cites [18] Levine, 2002, Human muscle sympathetic neural and haemodynamic responses to tilt following spaceflight, J Physiol source
- Premisecitation
Some POTS patients have inappropriately low plasma renin activity and aldosterone levels resulting in inadequate renal sodium retention.
“Some have inappropriately low plasma renin activity and aldosterone levels resulting in inadequate renal sodium retention (42,44).”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [42] Stewart, 2009, Defects in cutaneous angiotensin-converting enzyme 2 and angiotensin-(1-7) production in postural tachycardia syndrome, Hypertension source
The Introduction describes hypovolemia in a low-flow POTS subgroup and says increased angiotensin II was not accounted for by changes in renin. Neither it nor the other passages found by searching for renin, aldosterone, and sodium retention addresses inappropriately low plasma renin activity and aldosterone causing inadequate renal sodium retention. Page numbers were not available in our copy. (LLM, conf=0.76)
Experimental — accuracy not yet measured - cites [44] Mar, 2014, Neuronal and hormonal perturbations in postural tachycardia syndrome, Front Physiol source
- Premisecitation
More common than genetic NET deficiency is NET blockade from pharmacological agents, such as NE reuptake inhibitors, tricyclic antidepressants, and other sympathomimetic drugs.
“More common than genetic NET deficiency is NET blockade from pharmacological agents, such as NE reuptake inhibitors (e.g., bupropion), tricyclic antidepressants (e.g., nortriptyline), and other sympathomimetic drugs (e.g., methylphenidate) (15).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [15] Benarroch, 2012, Postural tachycardia syndrome: a heterogeneous and multifactorial disorder, Mayo Clin Proc source
The ARTICLE HIGHLIGHTS passage says that increased norepinephrine levels more commonly reflect pharmacological NET blockade than the genetic NET deficiency described in a case. It names tricyclic antidepressants, selective NET inhibitors, and amphetamine-like drugs including methylphenidate, but does not name bupropion or nortriptyline as the citing sentence does. (LLM, conf=0.85)
Experimental — accuracy not yet measured
- Premisecitation
The hyperadrenergic subtype may correspond to 30% to 60% of POTS patients.
“Another large subgroup within the POTS population is the so-called hyperadrenergic subtype, with features that may correspond to 30% to 60% of POTS patients (6,36,37).”
Quote in the paperNot a substantial claim1 of 3 sources checked- cites [6] Thieben, 2007, Postural orthostatic tachycardia syndrome: the Mayo clinic experience, Mayo Clin Proc source
- cites [36] Low, 2009, Postural tachycardia syndrome (POTS), J Cardiovasc Electrophysiol source
The Hyperadrenergic POTS section reports elevated norepinephrine in 29.0% of patients tested, and the HUT and Evaluation of Adrenergic Function section says about half have a hyperadrenergic response. These figures support the claim that hyperadrenergic features occur in a substantial subgroup, but the paper does not establish a 30%–60% prevalence for the subtype, which it defines using both a blood-pressure rise and elevated norepinephrine. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites [37] Benarroch, 2014, The clinical approach to autonomic failure in neurological disorders, Nat Rev Neurol source
- Interpretationcitation
These observations led to the concept that peripheral sympathetic denervation might lead to impaired vasoconstriction and increased venous pooling in lower extremities.
“These observations led to the concept that peripheral sympathetic denervation might lead to impaired vasoconstriction and increased venous pooling in lower extremities (34).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [34] Streeten, 1990, Pathogenesis of hyperadrenergic orthostatic hypotension. Evidence of disordered venous innervation exclusively in the lower limbs, J Clin Invest source
- Premisecitation
Hyperadrenergic POTS patients have elevated standing plasma norepinephrine levels (>600 pg/ml), reflecting an exaggerated sympathetic response.
“These patients have elevated standing plasma norepinephrine (NE) levels (>600 pg/ml), reflecting an exaggerated sympathetic response (6,36),”
Quote in the paperSubstantial claim1 of 2 sources checked - Premisecitation
There appear to be fluctuations in the renin-angiotensin-aldosterone system during different phases of the menstrual cycle that affect the orthostatic hemodynamic response in POTS.
“There also appear to be some fluctuations in the renin-angiotensin-aldosterone system during different phases of the menstrual cycle that affect the orthostatic hemodynamic response in POTS (45).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [45] Fu, 2010, Menstrual cycle affects renal-adrenal and hemodynamic responses during prolonged standing in the postural orthostatic tachycardia syndrome, Hypertension source
- Premisecitation
Others have elevated plasma angiotensin II levels suggesting inadequate angiotensin-converting enzyme 2 activity.
“Others have elevated plasma angiotensin II levels suggesting inadequate angiotensin-converting enzyme 2 activity (42,44).”
Quote in the paperNot a substantial claim2 of 2 sources checked - Premisecitation
Women with POTS often report fluctuations in the severity of POTS symptoms throughout their menstrual cycle, with worsening during either the pre-menstrual or early follicular phase when both estrogen and progesterone levels are dropping or low.
“Women with POTS often report fluctuations in the severity of POTS symptoms throughout their menstrual cycle, with worsening during either the pre-menstrual or early follicular phase when both estrogen and progesterone levels are dropping or low (6,9,45,51).”
Quote in the paperNot a substantial claim1 of 3 sources checked- cites [6] Thieben, 2007, Postural orthostatic tachycardia syndrome: the Mayo clinic experience, Mayo Clin Proc source
- cites [9] Raj, 2006, The postural tachycardia syndrome (POTS): pathophysiology, diagnosis & management, Indian Pacing Electrophysiol J
- cites [45] Fu, 2010, Menstrual cycle affects renal-adrenal and hemodynamic responses during prolonged standing in the postural orthostatic tachycardia syndrome, Hypertension source
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
- Premisecitation
Many studies have demonstrated that prolonged bedrest or microgravity exposure can result in a POTS-like syndrome characterized by a tachycardic orthostatic intolerance even in previously healthy and active individuals.
“Many studies have demonstrated that prolonged bedrest or microgravity exposure can result in a POTS-like syndrome characterized by a tachycardic orthostatic intolerance even in previously healthy and active individuals (17,18,25,27,57-60).”
Quote in the paperSubstantial claim1 of 3 sources checked- cites [17] Buckey, 1996, Orthostatic intolerance after spaceflight, J Appl Physiol (1985) source
- cites [18] Levine, 2002, Human muscle sympathetic neural and haemodynamic responses to tilt following spaceflight, J Physiol source
The Discussion (page not provided) reports greater tachycardia after spaceflight and describes earlier studies in which astronauts could not remain standing for 10 minutes. It also notes increased heart rates after head-down bed rest, but does not establish bed-rest-induced orthostatic intolerance or characterize the response as a POTS-like syndrome in previously healthy, active individuals. None of this study’s astronauts experienced presyncope during postflight tilt. (LLM, conf=0.85)
Experimental — accuracy not yet measured - cites [25] Perhonen, 2001, Cardiac atrophy after bed rest and spaceflight, J Appl Physiol (1985) source
- Premisecitation
When plasma volume, blood volume, and supine hemodynamics were measured in a cohort of POTS patients and controls, no variations were noted while comparing the mid-luteal phase to the early-follicular phase.
“When plasma volume, blood volume, and supine hemodynamics were measured in a cohort of POTS patients and controls, no variations were noted while comparing the mid-luteal phase to the early-follicular phase (45).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [45] Fu, 2010, Menstrual cycle affects renal-adrenal and hemodynamic responses during prolonged standing in the postural orthostatic tachycardia syndrome, Hypertension source
- Interpretationcitation
These findings suggest that the orthostatic tachycardia in POTS is a physiological compensatory response to the smaller stroke volume in the setting of cardiac atrophy and reduced blood volume.
“These findings suggest that the orthostatic tachycardia in POTS is a physiological compensatory response to the smaller stroke volume (61,62) in the setting of cardiac atrophy and reduced blood volume (Figure 2B).”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [61] Fu, 2006, Vasomotor sympathetic neural control is maintained during sustained upright posture in humans, J Physiol source
The Results report that heart rate rose while stroke volume fell during upright tilt, and the Discussion links falling stroke volume to sympathetic activation. However, the study involved healthy individuals; it does not establish that tachycardia in POTS compensates for smaller stroke volume. The citation is attached to the smaller-stroke-volume explanation, not specifically to the cardiac-atrophy and reduced-blood-volume phrase. (LLM, conf=0.85)
Experimental — accuracy not yet measured - cites [62] Joyner, 2008, POTS versus deconditioning: the same or different?, Clin Auton Res source
- Premisecitation
When the 10-min criterion for upright position was applied to these data, HUT and the active stand test were comparable.
“When the 10-min criterion for upright position was applied to these data, HUT and the active stand test were comparable (95).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [95] Plash, 2013, Diagnosing postural tachycardia syndrome: comparison of tilt testing compared with standing haemodynamics, Clin Sci (Lond) source
The Results section, “Diagnostic Characteristics of the 30 bpm Criterion” (page unavailable), reports comparable sensitivity at 10 minutes: 93% for tilt and 87% for standing. But specificity was substantially lower for tilt (40% versus 67%), so the tests were not comparable on both diagnostic measures under that criterion. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Premisecitation
Orthostatic intolerance has been reported to occur more frequently in patients with chronic pelvic pain, including interstitial cystitis, bladder pain syndrome, and myofascial pelvic pain.
“Orthostatic intolerance has been reported to occur more frequently in patients with chronic pelvic pain, including interstitial cystitis, bladder pain syndrome, and myofascial pelvic pain (92).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [92] Chelimsky, 2016, Autonomic testing in women with chronic pelvic pain, J Urol source
- Interpretationcitation
A potential etiology for the link between supine HR and sleep efficiency is less refreshing sleep due to increased sympathetic activation.
“a potential etiology for this link is less refreshing sleep due to increased sympathetic activation (84).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [84] Bagai, 2016, Objective sleep assessments in patients with postural tachycardia syndrome using overnight polysomnograms, J Clin Sleep Med source
The Polysomnogram Correlations section (page not provided) proposes that increased sympathetic activity may reduce sleep efficiency and lead to less restful sleep. But the reported link is with the change in heart rate from supine to standing, not supine heart rate itself. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Interpretationreasoning
POTS and CFS may exist along the same clinical spectrum.
“as such, they may exist along the same clinical spectrum (82).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [82] Okamoto, 2012, Neurohumoral and haemodynamic profile in postural tachycardia and chronic fatigue syndromes, Clin Sci (Lond) source
- Premisecitation
When the active stand test was compared with passive HUT, orthostatic tachycardia was noted to be greater with HUT than with the active stand test in both POTS patients and healthy controls.
“When the active stand test was compared with passive HUT, orthostatic tachycardia was noted to be greater with HUT than with the active stand test in both POTS patients and healthy controls.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [95] Plash, 2013, Diagnosing postural tachycardia syndrome: comparison of tilt testing compared with standing haemodynamics, Clin Sci (Lond) source
- Premisecitation
Orthostatic tachycardia is more pronounced in the morning.
“Orthostatic tachycardia is more pronounced in the morning, and the active stand test (or HUT) should be performed in the morning when possible (93).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [93] Brewster, 2012, Diurnal variability in orthostatic tachycardia: implications for the postural tachycardia syndrome, Clin Sci (Lond) source
- Premisecitation
In a retrospective study looking at GI transit in patients with POTS, two-thirds had abnormal gastric emptying.
“In a retrospective study looking at GI transit in patients with POTS, two-thirds had abnormal gastric emptying.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [87] Loavenbruck, 2015, Disturbances of gastrointestinal transit and autonomic functions in postural orthostatic tachycardia syndrome, Neurogastroenterol Motil source
- Premisecitation
Lower urinary tract symptoms, including increased daytime frequency, urgency, and nocturia have been reported at higher frequencies in POTS.
“Lower urinary tract symptoms, including increased daytime frequency, urgency, and nocturia have been reported at higher frequencies in POTS (90).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [90] Kaufman, 2017, Overactive bladder and autonomic dysfunction: lower urinary tract symptoms in females with postural tachycardia syndrome, Neurourol Urodyn source
The Results report that 13 of 19 women with POTS met criteria for probable overactive bladder and identify nocturia, frequency, and urgency as bothersome symptoms. The paper does not establish that each symptom occurs more frequently in POTS than in a comparison group, or separately quantify increased daytime frequency. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Premisecitation
Research has demonstrated that physical reconditioning with a short-term (3 month) progressive exercise training program leads to improvement or remission of POTS in the majority of patients.
“Research has demonstrated that physical reconditioning with a short-term (3 month) progressive exercise training program leads to improvement or remission of POTS in the majority of patients (4,64).”
Quote in the paperSubstantial claim1 of 2 sources checked - Premisecitation
A negative correlation between supine HR and sleep efficiency has been noted.
“A negative correlation between supine HR and sleep efficiency has been noted;”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [84] Bagai, 2016, Objective sleep assessments in patients with postural tachycardia syndrome using overnight polysomnograms, J Clin Sleep Med source
The 'Correlation between Polysomnogram Data and Autonomic Data' section reports negative correlations between sleep efficiency and maximal standing HR and the change in HR from supine to standing in POTS patients. It does not report a negative correlation with supine HR itself; the claim substitutes a different HR measure. (LLM, conf=0.87)
Experimental — accuracy not yet measured
- Premisecitation
Several other studies have implicated dysmotility at different levels of the GI tract (duodenal, gastric) in POTS.
“Several other studies have implicated dysmotility at different levels of the GI tract (duodenal, gastric) in POTS (87)(88)(89).”
Quote in the paperNot a substantial claim1 of 3 sources checked- cites [87] Loavenbruck, 2015, Disturbances of gastrointestinal transit and autonomic functions in postural orthostatic tachycardia syndrome, Neurogastroenterol Motil source
The Discussion reports abnormal gastric emptying in two-thirds of patients with POTS and GI symptoms, supporting the gastric part of the cited sentence. Although the paper also evaluated small-bowel transit, the passages do not establish duodenal dysmotility specifically. (LLM, conf=0.82)
Experimental — accuracy not yet measured - cites [88] Moak, 2016, Antroduodenal manometry is abnormal in children presenting with orthostatic intolerance and gastrointestinal symptoms, J Pediatr Gastroenterol Nutr source
- cites [89] Wang, 2015, Gastrointestinal dysfunction in postural tachycardia syndrome, J Neurol Sci source
- Premisecitation
Behavioral and cognitive therapy has been used to obtain long-term control of symptoms, particularly when anxiety, hypervigilance, or catastrophizing behaviors are present.
“Behavioral and cognitive therapy has been used to obtain long-term control of symptoms, particularly when anxiety, hypervigilance, or catastrophizing behaviors are present (15).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [15] Benarroch, 2012, Postural tachycardia syndrome: a heterogeneous and multifactorial disorder, Mayo Clin Proc source
In “Why Are Some Patients With POTS So Difficult to Treat?” (page not supplied), the paper identifies somatic hypervigilance as a factor in persistent symptoms and says behavioral-cognitive approaches are more likely than pharmacotherapy to improve quality of life. It does not report that therapy has been used to achieve long-term symptom control or specifically identify catastrophizing behaviors. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Premisecitation
A small study evaluating this showed that modafinil did not significantly worsen standing HR or orthostatic symptoms in POTS.
“A small study evaluating this showed that modafinil did not significantly worsen standing HR or orthostatic symptoms in POTS (115).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [115] Kpaeyeh, 2014, Hemodynamic profiles and tolerability of modafinil in the treatment of postural tachycardia syndrome: a randomized, placebo-controlled trial, J Clin Psychopharmacol source
- Premisecitation
In limited studies, ivabradine has also been shown to reduce HR in POTS.
“In limited studies, ivabradine has also been shown to reduce HR in POTS (112,113).”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [112] McDonald, 2011, Single centre experience of ivabradine in postural orthostatic tachycardia syndrome, Europace source
The Results report that patients taking ivabradine experienced fewer episodes of palpitations and tachycardia, and the Discussion describes reduced patient-perceived tachycardia in 55% of POTS patients. The study relied on symptom reports rather than measured heart-rate changes, so it does not establish the claimed reduction in HR directly. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites [113] Barzilai, 2015, The effect of ivabradine on the heart rate and sympathovagal balance in postural tachycardia syndrome patients, Rambam Maimonides Med J source
- Premisecitation
Patients with hyperadrenergic POTS or significant hypertensive responses during tilt may respond to phenobarbital.
“Patients with hyperadrenergic POTS or significant hypertensive responses during tilt may respond to phenobarbital 15 mg in the morning and 60 mg at night (36).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [36] Low, 2009, Postural tachycardia syndrome (POTS), J Cardiovasc Electrophysiol source
The Management > Hyperadrenergic POTS passage says that some patients with autonomic instability and unstable hypertensive responses to tilt respond to oral phenobarbital, beginning with 60 mg at night and 15 mg in the morning. It does not extend that treatment response to hyperadrenergic POTS patients generally; it describes a particularly difficult subset. (LLM, conf=0.82)
Experimental — accuracy not yet measured
- Premisecitation
Selective serotonin reuptake inhibitors have not been shown to reduce tachycardia in POTS.
“They have not been shown to reduce tachycardia in POTS (110).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [110] Mar, 2014, Acute hemodynamic effects of a selective serotonin reuptake inhibitor in postural tachycardia syndrome: a randomized, crossover trial, J Psychopharmacol source
The Discussion conclusion reports that acute sertraline did not significantly reduce heart rate in POTS patients. The study tested one SSRI over a short period, and the Discussion says longer-duration studies are needed; it does not establish the broader claim for SSRIs generally or chronic use. (LLM, conf=0.87)
Experimental — accuracy not yet measured
- Premisecitation
Perceptual amplification and hypervigilance have more recently been expanded to explain some symptoms and comorbid conditions associated with POTS.
“This has more recently been expanded to explain some of the symptoms and comorbid conditions associated with POTS(79).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [79] Owens, 2017, The genesis and presentation of anxiety in disorders of autonomic overexcitation, Auton Neurosci source
- Interpretationcitation
POTS is simply another comorbid condition rather than the cause of these other conditions.
“Several recent studies have shown that these comorbidities occur in increased frequency with each other regardless of whether a patient has POTS, suggesting that POTS is simply another comorbid condition rather than the cause of these other conditions(69).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [69] Chelimsky, 2015, Comorbid conditions do not differ in children and young adults with functional disorders with or without postural tachycardia syndrome, J Pediatr source
- Premisecitation
Several recent studies have shown that comorbidities occur in increased frequency with each other regardless of whether a patient has POTS.
“Several recent studies have shown that these comorbidities occur in increased frequency with each other regardless of whether a patient has POTS, suggesting that POTS is simply another comorbid condition rather than the cause of these other conditions(69).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [69] Chelimsky, 2015, Comorbid conditions do not differ in children and young adults with functional disorders with or without postural tachycardia syndrome, J Pediatr source
The Results and Discussion (page unavailable) find similar comorbidity burdens with and without POTS and report associations among some conditions, particularly fibromyalgia and hypermobility. The paper says this pattern suggests POTS is another comorbid condition rather than the cause of the others. It does not show that all the comorbidities occur together at increased frequency; the Discussion calls the fibromyalgia–hypermobility link the only reliable association found in the study. (LLM, conf=0.84)
Experimental — accuracy not yet measured
- Premisecitation
POTS patients often have numerous comorbidities including chronic fatigue, dizziness, syncope, migraines, functional GI disorders, chronic nausea, fibromyalgia, and joint hypermobility.
“These are numerous and include chronic fatigue, dizziness, syncope, migraines, functional GI disorders, chronic nausea, fibromyalgia, and joint hypermobility among others(68).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [68] Kizilbash, 2014, Adolescent fatigue, POTS, and recovery: a guide for clinicians, Curr Probl Pediatr Adolesc Health Care source
The POTS sections on typical presentations and GI physiology (page unavailable) describe fatigue, dizziness, nausea, migraine-like headaches, functional GI symptoms, and joint hypermobility; the recovery section also lists fainting among POTS symptoms. But the recovery section calls fibromyalgia a syndrome with features similar to POTS, not a frequent POTS comorbidity. The source also describes several listed items as symptoms rather than separate comorbid conditions. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Premisecitation
In POTS patients, the average HR increment from supine to upright is 44.2 ± 13.2 beats/min.
“with an average HR increment of 44.2 Æ 13.2 beats/min from supine to upright (6)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [6] Thieben, 2007, Postural orthostatic tachycardia syndrome: the Mayo clinic experience, Mayo Clin Proc source
- Premisecitation
Under thermal stress, cutaneous vasodilation increases blood flow to the skin and redirects up to 50% to 70% of resting cardiac output to the skin to maintain core temperature.
“Under thermal stress, cutaneous vasodilation increases blood flow to the skin and redirects up to 50% to 70% of resting cardiac output to the skin to maintain core temperature (14).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [14] Rowell, 1986, Circulatory adjustments to dynamic exercise and heat stress: competing controls
Not checked in the free run.
- Premisecitation
Cardiovascular deconditioning can occur rapidly, within 20 h of bedrest.
“Cardiovascular deconditioning can occur rapidly, within 20 h of bedrest (27);”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [27] Gaffney, 1985, Cardiovascular deconditioning produced by 20 hours of bedrest with head-down tilt (-5 degrees) in middle-aged healthy men, Am J Cardiol source
- Premisecitation
Women, the predominant group afflicted by POTS, appear to be more susceptible to cardiovascular deconditioning.
“like with spaceflight, women, the predominant group afflicted by POTS, appear to be more susceptible (16,28,29).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [16] Fritsch-Yelle, 1996, Subnormal norepinephrine release relates to presyncope in astronauts after spaceflight, J Appl Physiol (1985) source
- cites [28] Waters, 2002, Postspaceflight orthostatic hypotension occurs mostly in women and is predicted by low vascular resistance, J Appl Physiol (1985) source
- cites [29] Fu, 2010, Why do young women (donors) faint?, Transfusion source
- Premisecitation
The same mechanisms described in space flight have also been seen following prolonged bedrest deconditioning.
“These same mechanisms described in space flight have also been seen following prolonged bedrest deconditioning (23,(25)(26)(27).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [23] Levine, 1997, Cardiac atrophy after bed-rest deconditioning: a nonneural mechanism for orthostatic intolerance, Circulation source
- cites [25] Perhonen, 2001, Cardiac atrophy after bed rest and spaceflight, J Appl Physiol (1985) source
- cites [26] Raj
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
In one study, more than 50% of POTS patients were noted to have loss of sweat function in distal lower extremities, measured as impaired sweat volume on quantitative sudomotor axon reflex testing or reduced intraepidermal C-fiber density on skin biopsy.
“In one study, >50% of POTS patients (6) were noted to have loss of sweat function in distal lower extremities (32), measured as impaired sweat volume on quantitative sudomotor axon reflex testing (32) or reduced intraepidermal C-fiber density on skin biopsy (33).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [6] Thieben, 2007, Postural orthostatic tachycardia syndrome: the Mayo clinic experience, Mayo Clin Proc source
- cites [32] Raj, 2007, Blood volume perturbations in the postural tachycardia syndrome, Am J Med Sci source
- cites [33] Haensch, 2014, Small-fiber neuropathy with cardiac denervation in postural tachycardia syndrome, Muscle Nerve source
- Premisenone given
Physiological cardiac atrophy in response to bedrest deconditioning, like physiological hypertrophy in response to exercise training, is a universal response to cardiac unloading and by itself is not pathological.
“physiological cardiac atrophy in response to bedrest deconditioning, like its converse, physiological hypertrophy in response to exercise training, is a universal response to cardiac unloading, and by itself, is not pathological.”
Quote in the paperSubstantial claim - Interpretationreasoning
In susceptible patients, even mild post-bedrest orthostatic intolerance may lead to a downward spiral of further bedrest deconditioning and worsening orthostatic intolerance that can be quite debilitating.
“in susceptible patients, even mild post-bedrest orthostatic intolerance may lead to a “downward spiral” of further bedrest deconditioning and worsening orthostatic intolerance that can be quite debilitating.”
Quote in the paperSubstantial claim- Rests on an assumption: A period of enforced bedrest is often a common theme in patients with POTS, even those who have previously been quite active.
- Rests on an assumption: In many cases, patients with POTS relate a healthy and active premorbid state; some are competitive athletes or high-performing high school or college students before developing POTS.
- Premisenone given
A single case of POTS with elevated standing NE levels was found to have a mutation in NET, encoded by the SLC6A2 gene, causing loss of function.
“A single case of POTS with elevated standing NE levels was found to have a mutation in NET, encoded by the SLC6A2 gene, causing loss of function;”
Quote in the paperNot a substantial claim - Premisecitation
Stimulant-induced tachycardia has been known to closely mimic POTS.
“Stimulant-induced tachycardia has been known to closely mimic POTS (41),”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [41] Cheshire, 2016, Stimulant medication and postural orthostatic tachycardia syndrome: a tale of two cases, Clin Auton Res source
- Premisereasoning
An autoimmune basis for POTS has been suggested on the basis of clinical associations, including subacute onset in the setting of stress or viral illness, and occasional association with a personal or family history of systemic autoimmune disorders such as Sjogren's syndrome.
“An autoimmune basis for POTS has been suggested on the basis of some of the clinical associations, including subacute onset in the setting of stress or viral illness, and the occasional association of POTS with a personal or family history of systemic autoimmune disorders such as Sjogren's syndrome.”
Quote in the paperNot a substantial claim - Premisecitation
When sodium intake is controlled, approximately 30% of POTS patients have evidence of hypovolemia based on <100 mEq of urinary sodium excretion in 24 h.
“When sodium intake is controlled, urine sodium excretion can be used as a surrogate for hypovolemia, and approximately 30% of POTS patients have evidence of hypovolemia based on <100 mEq of urinary sodium excretion in 24 h (6).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [6] Thieben, 2007, Postural orthostatic tachycardia syndrome: the Mayo clinic experience, Mayo Clin Proc source
- Premisecitation
Intolerance to orthostasis tends to be more significant in young women compared with their male counterparts.
“Intolerance to orthostasis tends to be more significant in young women compared with their male counterparts (29).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [29] Fu, 2010, Why do young women (donors) faint?, Transfusion source
- Premisereasoning
None of the autoantibody associations have been convincingly proven to be pathophysiologically or diagnostically important.
“Thus far, however, none of the autoantibody associations have been convincingly proven to be pathophysiologically or diagnostically important.”
Quote in the paperSubstantial claim - Premisecitation
More focused studies attempting to tie genetic variations in the SLC6A2 gene to elevated NE levels have been inconclusive.
“More focused studies attempting to tie genetic variations in the SLC6A2 gene to elevated NE levels, however, have been inconclusive (39,40).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [39] Ivancsits, 2003, Orthostatic intolerance is not necessarily related to a specific mutation (Ala457Pro) in the human norepinephrine transporter gene, Am J Med Sci source
- cites [40] Bayles, 2012, Epigenetic modification of the norepinephrine transporter gene in postural tachycardia syndrome, Arterioscler Thromb Vasc Biol source
- Premisecitation
Orthostatic HR increments have been shown to be larger in the morning than in the afternoon.
“Orthostatic HR increments have been shown to be larger in the morning than in the afternoon (55).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [55] Moon, 2016, The complexity of diagnosing postural orthostatic tachycardia syndrome: influence of the diurnal variability, J Am Soc Hypertens source
- Premisenone given
Unlike in POTS, the paroxysmal symptoms of pheochromocytoma are not positional.
“However, unlike in POTS, these paroxysmal symptoms are not positional.”
Quote in the paperNot a substantial claim - Premisecitation
Reconditioning via exercise may not improve all symptoms.
“Reconditioning via exercise may not improve all symptoms (101).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [101] Galbreath, 2011, Effects of exercise training on arterial-cardiac baroreflex function in POTS, Clin Auton Res source
- Interpretationcitation
This is felt to be a reflection of exaggerated sympathetic neuronal activation.
“This is felt to be a reflection of exaggerated sympathetic neuronal activation (97).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [97] Raj, 2013, Postural tachycardia syndrome (POTS), Circulation source
- Premisecitation
Cardiac arrhythmias following isoproterenol administration have been reported.
“Furthermore, cardiac arrhythmias following isoproterenol administration have been reported (96).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [96] Aerts, 2003, Nitrate stimulated tilt table testing: a review of the literature, Pacing Clin Electrophysiol source
- Premisecitation
There is no apparent difference in prevalence between the incidence of joint hypermobility in POTS patients and patients with other underlying chronic functional conditions.
“In fact, there is no apparent difference in prevalence between the incidence of joint hypermobility in POTS patients and patients with other underlying chronic functional conditions.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [71] Chelimsky, 2016, Benign joint hypermobility minimally impacts autonomic abnormalities in pediatric subjects with chronic functional pain disorders, J Pediatr source
- Interpretationcitation
This higher incidence of orthostatic intolerance may be related to perceptual amplification and hypervigilance, which have been well-described in pain conditions.
“This higher incidence of orthostatic intolerance may be related to perceptual amplification and hypervigilance, which have been well-described in pain conditions (77).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [77] McDermid, 1996, Generalized hypervigilance in fibromyalgia: evidence of perceptual amplification, Pain source
- Premisecitation
When asked to quantify and qualify their symptoms, POTS patients score higher on fatigue scales than they do sleepiness scales.
“When asked to quantify and qualify their symptoms, POTS patients score higher on fatigue scales than they do sleepiness scales,”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [86] Miglis, 2016, Sleep disorders in patients with postural tachycardia syndrome, Clin Auton Res source
- Premisecitation
Patients with MCAD may also demonstrate hyperadrenergic POTS features with testing, such as an exaggerated BP overshoot during recovery after the Valsalva maneuver.
“Patients with MCAD may also demonstrate hyperadrenergic POTS features with testing, such as an exaggerated BP overshoot during recovery after the Valsalva maneuver (46).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [46] Shibao, 2005, Hyperadrenergic postural tachycardia syndrome in mast cell activation disorders, Hypertension source
- Premisecitation
Physical maneuvers such as leg crossing, muscle tensing, and squatting have been shown to be effective in postponing and in some subjects preventing vasovagal syncope if used at the onset of prodromal symptoms.
“Physical maneuvers such as leg crossing, muscle tensing, and squatting have been shown to be effective in postponing and in some subjects preventing vasovagal syncope if used at the onset of prodromal symptoms (102,103).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
Chronic fatigue syndrome and fibromyalgia are comorbidities frequently associated with POTS.
“Chronic fatigue syndrome (CFS) and fibromyalgia are comorbidities frequently associated with POTS.”
Quote in the paperNot a substantial claim - Interpretationreasoning
The association between concussion and POTS may in part be related to deconditioning because physical activity withdrawal and increased bedrest are typically recommended following a concussion.
“As with other POTS triggers, this may in part be related to deconditioning, because a period of physical activity withdrawal and increased bedrest is typically recommended following a concussion.”
Quote in the paperNot a substantial claim - Premisecitation
In a follow-up of a small number of patients who participated in the exercise program in a community setting, the effectiveness persisted for at least 1 year.
“In a follow-up of a small number of patients who participated in the exercise program in a community setting, the effectiveness persisted for at least 1 year (64).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [64] George, 2016, The international POTS registry: Evaluating the efficacy of an exercise training intervention in a community setting, Heart Rhythm source
- Premisecitation
Medication effects of stimulant medications such as amphetamines have been reported as mimicking the tachycardia of POTS.
“Additionally, medication effects of stimulant medications such as amphetamines have been reported as mimicking the tachycardia of POTS (41).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [41] Cheshire, 2016, Stimulant medication and postural orthostatic tachycardia syndrome: a tale of two cases, Clin Auton Res source
- Premisecitation
Some patients with MCAD and associated POTS anecdotally responded to H1 and H2 histamine receptor blockers, the sympatholytic alphamethyldopa, or both.
“Some patients with MCAD and associated POTS anecdotally responded to H 1 and H 2 histamine receptor blockers, the sympatholytic alphamethyldopa, or both (46).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [46] Shibao, 2005, Hyperadrenergic postural tachycardia syndrome in mast cell activation disorders, Hypertension source
- Premisecitation
There are data that support the efficacy of biobehavioral treatments to reduce headache, abdominal pain, and fibromyalgia in the child and adolescent populations.
“Additionally, there are data that support the efficacy of biobehavioral treatments to reduce headache, abdominal pain, and fibromyalgia in the child and adolescent populations (117);”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [117] Palermo, 2010, Randomized controlled trials of psychological therapies for management of chronic pain in children and adolescents: an updated meta-analytic review, Pain source
- Premisecitation
In the same series, beta-blockers triggered episodes of worsening symptoms in several patients.
“Of note, in the same series, beta-blockers triggered episodes of worsening symptoms in several patients and should be used with caution if MCAD is suspected.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [46] Shibao, 2005, Hyperadrenergic postural tachycardia syndrome in mast cell activation disorders, Hypertension source
- May combine two claims. 56
- Classified as probably not a substantial claim. 27
May combine two claims.
PremisecitationNondipping POTS patients demonstrate significantly greater orthostatic HR increment and a significantly greater orthostatic plasma NE rise compared with matched dipping controls.
“These patients also demonstrate significantly greater orthostatic HR increment and a significantly greater orthostatic plasma NE rise compared with matched dipping controls (56),”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [56] Figueroa, 2014, Decreased orthostatic adrenergic reactivity in non-dipping postural tachycardia syndrome, Auton Neurosci source
The Results (Autonomic Function Tests, BP monitoring, and Laboratory Data; page not provided) report the opposite direction: dipping POTS patients had significantly greater orthostatic heart-rate increments and plasma norepinephrine increases than non-dippers. The Discussion likewise describes lower adrenergic reactivity in non-dippers. (LLM, conf=0.95)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationPOTS has a prevalence of 0.2%.
“with a prevalence of 0.2% (1)”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [1] Sheldon, 2015, 2015 Heart Rhythm Society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope, Heart Rhythm source
May combine two claims.
PremisecitationHealthy women have smaller stroke volumes and higher HRs compared with healthy men, whereas women with POTS have both an exaggerated fall in stroke volume and an apparent compensatory rise in HR.
“healthy women have smaller stroke volumes and higher HRs compared with healthy men, whereas women with POTS have both an exaggerated fall in stroke volume and an apparent compensatory rise in HR.”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [4] Fu, 2010, Cardiac origins of the postural orthostatic tachycardia syndrome, J Am Coll Cardiol source
The Discussion (page unavailable) reports smaller upright stroke volume and greater heart rate in POTS patients than in healthy controls, and describes the tachycardia as an apparent compensatory response. It also says healthy women have smaller hearts than men, but does not establish that healthy women have smaller stroke volumes and higher heart rates than men. Nor does it directly establish an exaggerated fall in stroke volume in the POTS patients studied, as distinct from a smaller upright stroke volume. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites [12] Fu, 2009, Menstrual cycle effects on sympathetic neural responses to upright tilt, J Physiol source
The Responses during upright tilt section reports lower stroke volumes in healthy women than men, while heart rates only tended to be higher. The Study limitations section says all participants were healthy; the paper does not support the claim about an exaggerated stroke-volume fall or compensatory heart-rate rise in women with POTS. Page numbers were not available in our copy. (LLM, conf=0.88)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationPre-syncope is much more common than syncope in POTS, but POTS coexists with episodes of neurally mediated (reflex) syncope.
“Pre-syncope is much more common than syncope in POTS, but it is not infrequent that POTS coexists with episodes of neurally mediated (reflex) syncope (1).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [1] Sheldon, 2015, 2015 Heart Rhythm Society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope, Heart Rhythm source
May combine two claims.
PremisecitationSome POTS patients have persistently low plasma volumes, which evidence suggests is perhaps secondary to impaired function of the renin-angiotensin-aldosterone system.
“Some POTS patients have been noted to have persistently low plasma volumes (32,(42)(43)(44), which evidence suggests is perhaps secondary to impaired function of the renin-angiotensin-aldosterone system.”
Quote in the paperNot a substantial claim1 of 3 sources checked- cites [32] Raj, 2007, Blood volume perturbations in the postural tachycardia syndrome, Am J Med Sci source
- cites [42] Stewart, 2009, Defects in cutaneous angiotensin-converting enzyme 2 and angiotensin-(1-7) production in postural tachycardia syndrome, Hypertension source
The Introduction (page unavailable) describes a low-flow POTS subgroup with hypovolemia. The Discussion (page unavailable) suggests an ACE2-related angiotensin defect, but links it to excessive vasoconstriction, not to the cause of low plasma volume. The paper also does not establish that the low volume is persistent. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites [43] Li, 2015, [Relationship between 24-hour urinary sodium and renin-angiotensin-aldosterone system in children with postural tachycardia syndrome], Zhonghua Yi Xue Za Zhi
May combine two claims.
PremisecitationExercise training has been demonstrated to expand blood volume and increase cardiac size and mass in POTS patients and result in a prominent decrease in symptoms.
“the positive response these patients have to exercise training, which has been demonstrated to expand blood volume and increase cardiac size and mass in POTS patients and result in a prominent decrease in symptoms (4,63,64).”
Quote in the paperSubstantial claim1 of 3 sources checked- cites [4] Fu, 2010, Cardiac origins of the postural orthostatic tachycardia syndrome, J Am Coll Cardiol source
- cites [63] Dorfman, 2007, Cardiac atrophy in women following bed rest, J Appl Physiol (1985) source
- cites [64] George, 2016, The international POTS registry: Evaluating the efficacy of an exercise training intervention in a community setting, Heart Rhythm source
May combine two claims.
PremisecitationIn POTS patients, cardiac output and stroke volume were lower, and total peripheral vascular resistance higher, during the early-follicular phase.
“However, in POTS patients, cardiac output and stroke volume were lower, and total peripheral vascular resistance higher, during the early-follicular phase.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [45] Fu, 2010, Menstrual cycle affects renal-adrenal and hemodynamic responses during prolonged standing in the postural orthostatic tachycardia syndrome, Hypertension source
The Results (EFP versus MLP; page not provided) report lower cardiac output and stroke volume and greater total peripheral resistance in POTS women during the early-follicular phase than the mid-luteal phase. The claim omits the condition that these differences appeared only after 30 minutes of standing; supine measurements and responses during the initial 30 minutes did not differ between phases. (LLM, conf=0.88)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationMultiple parameters associated with deconditioning have been demonstrated in POTS patients, including reduced cardiac size and mass (by 16%), reduced blood volume (by 20%), reduced stroke volume, and reduced peak oxygen uptake (VO2 peak) when compared with matched sedentary controls.
“Multiple parameters associated with deconditioning have also been demonstrated in POTS patients, including reduced cardiac size and mass (by 16%), reduced blood volume (by 20%), reduced stroke volume, and reduced peak oxygen uptake (VO 2 peak) when compared with matched sedentary controls (4).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [4] Fu, 2010, Cardiac origins of the postural orthostatic tachycardia syndrome, J Am Coll Cardiol source
The Discussion (POTS and “deconditioning”; page unavailable) reports approximately 16% lower left ventricular mass, 20% lower blood and plasma volume, and markedly smaller upright stroke volume in POTS patients than in healthy sedentary controls. The Results (Exercise training effects; page unavailable) show that peak oxygen uptake increased after training in POTS patients, but do not establish that it was lower than in controls. The 16% figure applies specifically to left ventricular mass, not cardiac size as well. (LLM, conf=0.87)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationIn POTS patients who do get overnight polysomnography, no objective sleep parameter abnormalities are typically identified, and findings are comparable to those of healthy controls.
“In POTS patients who do get overnight polysomnography, no objective sleep parameter abnormalities are typically identified, and findings are comparable to those of healthy controls (84,85).”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [84] Bagai, 2016, Objective sleep assessments in patients with postural tachycardia syndrome using overnight polysomnograms, J Clin Sleep Med source
- cites [85] Pengo, 2015, Characterisation of sleep disturbances in postural orthostatic tachycardia syndrome: a polysomnography-based study, Sleep Med source
May combine two claims.
PremisecitationBoth POTS and CFS patients share many of the same characteristics including small hearts and lab markers of excessive sympathetic activation.
“Not surprisingly, both POTS and CFS patients share many of the same characteristics including small hearts (81) and lab markers of excessive sympathetic activation;”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [81] Miwa, 2008, Small heart syndrome in patients with chronic fatigue syndrome, Clin Cardiol source
The Abstract reports small hearts in 61% of patients with CFS, compared with 24% of controls. That supports the CFS portion of the cited small-heart claim, but the study did not examine POTS patients, so it cannot establish that both groups share this characteristic. The citation is attached to “small hearts,” not to the subsequent claim about lab markers. (LLM, conf=0.86)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationThe majority of these patients had rapid gastric emptying, but a smaller subset had delayed gastric emptying.
“The majority of these patients had rapid gastric emptying, but a smaller subset had delayed gastric emptying (87);”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [87] Loavenbruck, 2015, Disturbances of gastrointestinal transit and autonomic functions in postural orthostatic tachycardia syndrome, Neurogastroenterol Motil source
The Results (Demographic Features, Clinical Characteristics and Gastrointestinal Transit) report rapid gastric emptying in 78 of 163 patients (48%) and delayed emptying in 30 (18%). Rapid emptying was the most common finding, but 48% is not a majority of all patients. (LLM, conf=0.90)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationPatient quality of life improved after exercise training but not with propranolol treatment.
“Patient quality of life also improved after exercise training, but not with propranolol treatment (98).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [98] Fu, 2011, Exercise training versus propranolol in the treatment of the postural orthostatic tachycardia syndrome, Hypertension source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationChronic fatigue has been cited in up to 48% of POTS patients, and patients with CFS often have POTS as well.
“Chronic fatigue has been cited in up to 48% of POTS patients (6), and patients with CFS often have POTS as well (81).”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [6] Thieben, 2007, Postural orthostatic tachycardia syndrome: the Mayo clinic experience, Mayo Clin Proc source
- cites [81] Miwa, 2008, Small heart syndrome in patients with chronic fatigue syndrome, Clin Cardiol source
Citation (81) is attached to the claim that patients with CFS often have POTS; the 48% figure is attached to a different citation. The Physical Examination Findings (p. 330) report orthostatic dizziness in some patients with CFS, but our copy does not identify it as POTS or report POTS prevalence. Searches for “POTS” and “orthostatic tachycardia” found no passage establishing the claimed overlap. (LLM, conf=0.76)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationThe majority of patients who complete the exercise training program no longer meet criteria for POTS, and the vast majority, if not all, report improved quality of life using a reliable and valid questionnaire.
“The majority of patients who complete the exercise training program no longer meet criteria for POTS, and the vast majority, if not all patients, report improved quality of life using a reliable and valid questionnaire (4,101).”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [4] Fu, 2010, Cardiac origins of the postural orthostatic tachycardia syndrome, J Am Coll Cardiol source
The Results (Exercise training effects; page unavailable) report that 10 of 19 completers no longer met POTS criteria and that quality of life improved after training. The Methods identify the questionnaire as the SF-36, but our copy does not establish the claim that it is reliable and valid. (LLM, conf=0.85)
Experimental — accuracy not yet measured - cites [101] Galbreath, 2011, Effects of exercise training on arterial-cardiac baroreflex function in POTS, Clin Auton Res source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationClonidine can be used to reduce autonomic instability in similar patients.
“Clonidine (a central sympatholytic) 0.1 mg twice daily can be used to reduce autonomic instability in similar patients (36).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [36] Low, 2009, Postural tachycardia syndrome (POTS), J Cardiovasc Electrophysiol source
May combine two claims.
PremisecitationPyridostigmine can increase parasympathetic autonomic tone and has a lower risk of hypertension compared with other medications.
“Pyridostigmine (a cholinergic agonist that works by inhibiting acetylcholinesterase) 30 to 60 mg 3 times a day can increase parasympathetic autonomic tone (107,108) and has a lower risk of hypertension compared with other medications.”
Quote in the paperSubstantial claim1 of 2 sources checkedMay combine two claims.
PremisecitationThe supine hypertension that accompanies NOH leads to increased nocturnal diuresis, which in turn worsens orthostatic intolerance, particularly in the morning.
“the supine hypertension that accompanies NOH leads to increased nocturnal diuresis, which in turn worsens orthostatic intolerance, particularly in the morning.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [106] Gibbons, 2017, The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension, J Neurol source
May combine two claims.
PremisecitationIn a double-blind drug trial, propranolol was effective at reducing standing HR, but exercise training was superior to propranolol at restoring upright hemodynamics and normalizing renal-adrenal responsiveness.
“Even though propranolol was also effective at reducing standing HR, exercise training was found to be superior to propranolol at restoring upright hemodynamics and normalizing renal-adrenal responsiveness.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [98] Fu, 2011, Exercise training versus propranolol in the treatment of the postural orthostatic tachycardia syndrome, Hypertension source
May combine two claims.
PremisecitationAlthough long-acting propranolol has been demonstrated to reduce standing HR in POTS, this medication did not improve quality of life.
“However, although long-acting propranolol has been demonstrated to reduce standing HR in POTS, this medication did not improve quality of life (98).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [98] Fu, 2011, Exercise training versus propranolol in the treatment of the postural orthostatic tachycardia syndrome, Hypertension source
Classified as probably not a substantial claim.
PremisecitationA regular, structured, progressive exercise program is a Heart Rhythm Society Class IIa recommendation for the treatment of POTS.
“A regular, structured, and progressive exercise program is a Heart Rhythm Society (HRS) Class IIa recommendation for the treatment of POTS, and it may receive enhanced recommendation based on recent data and lack of other proven effective therapies (1).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [1] Sheldon, 2015, 2015 Heart Rhythm Society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope, Heart Rhythm source
The POTS Treatment section recommends a regular, structured, graduated exercise program, supporting the exercise recommendation. The passages in our copy do not state its HRS recommendation class, so the specific Class IIa designation is not verified. (LLM, conf=0.78)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationIn POTS patients, the mean age is 30.2 ± 10.3 years and 86% are women.
“The typical demographic is young women (mean age 30.2 Æ 10.3 years, 86% women)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [6] Thieben, 2007, Postural orthostatic tachycardia syndrome: the Mayo clinic experience, Mayo Clin Proc source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationPOTS affects an estimated 500,000 Americans based on a 1999 report.
“affecting an estimated 500,000 Americans based on a 1999 report (2).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [2] Robertson, 1999, The epidemic of orthostatic tachycardia and orthostatic intolerance, Am J Med Sci source
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
InterpretationreasoningThe prevalence of POTS may have increased over the past 2 decades due to increased awareness of the syndrome.
“due to increased awareness of the syndrome, the prevalence of POTS may have increased over the past 2 decades.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisereasoningNot all patients with orthostatic intolerance have POTS, though all patients with POTS have symptoms of orthostatic intolerance.
“Not all patients with orthostatic intolerance have POTS, though all patients with POTS have symptoms of orthostatic intolerance.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe onset of POTS can be subacute (13.8%), insidious (5.9%), or acute (12.5%).
“The onset of POTS can be subacute (13.8%), insidious (5.9%), or acute (12.5%).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [6] Thieben, 2007, Postural orthostatic tachycardia syndrome: the Mayo clinic experience, Mayo Clin Proc source
May combine two claims.
InterpretationreasoningHeat stress dramatically decreases orthostatic tolerance in healthy humans, and this is why orthostatic intolerance of all types, including POTS, is worsened by heat.
“Heat stress dramatically decreases orthostatic tolerance in healthy humans, and this is why orthostatic intolerance of all types (including POTS) is worsened by heat.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationCentral blood volume plays a critical role in the acute regulation of the sympathetic nervous system; volume loading induces virtual sympathetic silence, and volume unloading causes marked sympathetic activation.
“Central blood volume plays a critical role in the acute regulation of the sympathetic nervous system; volume loading induces virtual sympathetic silence, and volume unloading causes marked sympathetic activation.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [11] Pawelczyk, 2001, Regulation of muscle sympathetic nerve activity after bed rest deconditioning, Am J Physiol Heart Circ Physiol source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationPOTS is frequently preceded by symptoms of a viral illness (42%) or may occur post-operatively (9.5%).
“It is frequently preceded by symptoms of a viral illness (in 42%) or may occur post-operatively (in 9.5%) (6).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [6] Thieben, 2007, Postural orthostatic tachycardia syndrome: the Mayo clinic experience, Mayo Clin Proc source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Interpretationnone givenSymptoms commonly associated with POTS may not be part of a single unifying underlying disease process or linked clearly by a common pathophysiology.
“they may not be part of a single unifying, underlying disease process, or linked clearly by a common pathophysiology.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningAlthough the mechanisms have not specifically been shown to cause POTS, there are remarkable similarities between the effects of spaceflight/bedrest and POTS, which may be informative for considering POTS pathophysiology.
“Though these mechanisms have not specifically been shown to “cause” POTS, there are remarkable similarities between the effects of spaceflight/bedrest and POTS, which may be informative in considering the potential pathophysiology of POTS.”
Quote in the paperSubstantial claimMay combine two claims.
Study design and conductnone givenThe findings on lower-extremity blood flow POTS subgroups have not been demonstrated prospectively, and differentiating POTS subgroups based on lower extremity blood flow has not been shown to lead to unique therapies.
“However, these findings have not been demonstrated prospectively, and differentiating POTS subgroups based on lower extremity blood flow have not been shown to lead to unique therapies.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationcitationRegardless of the precipitating cause, the state of cardiovascular deconditioning often dominates the clinical picture and is a major cause of functional disability.
“Ultimately, regardless of the precipitating cause, the state of cardiovascular deconditioning often dominates the clinical picture and is a major cause of functional disability (26).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [26] Raj
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
PremisecitationIn a cohort study of unselected POTS patients, the prevalence of ganglionic AChR antibodies (always at low antibody levels) was <5%, and this antibody frequency was not statistically different from population controls.
“In a cohort study of unselected POTS patients, the prevalence of ganglionic AChR antibodies (always at low antibody levels) was <5%, and this antibody frequency was not statistically different from population controls (48,49).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [48] Vernino, 2015, Prevalence of ganglionic AChR antibodies in postural tachycardia syndrome (POTS) (abstr), Neurology source
- cites [49] Vernino S, Bryarly M, Hopkins S, et al. The prevalence of galgnion AChR antibodies in postural tachycardia syndrome (POTS). Paper presented at: 27th International Symposium on the Autonomic Nervous System; November 3, 2016; San Diego, CA.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
Study design and conductnone givenThe finding on nondipping POTS patients has not yet been reproduced, and its significance is currently unclear.
“This finding has not yet been reproduced, however, and its significance is currently unclear.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisenone givenBy contrast, the tachycardia in POTS is triggered by orthostatic stress, and POTS patients usually have a normal resting supine HR.
“By contrast, the tachycardia in POTS is triggered by orthostatic stress, and POTS patients usually have a normal resting supine HR.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationInappropriate sinus tachycardia is sometimes confused with POTS, but occurs independent of body position.
“Inappropriate sinus tachycardia (IST) is sometimes confused with POTS, but occurs independent of body position (66).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [66] Pellegrini, 2016, Epidemiology and definition of inappropriate sinus tachycardia, J Interv Card Electrophysiol source
May combine two claims.
PremisereasoningNeurally mediated syncope is not synonymous with POTS and is a separate problem, but NMS can lead to similar symptoms of orthostatic intolerance particularly in the immediately pre-syncopal phase.
“Neurally mediated syncope (NMS) (“vasovagal” or reflex) syncope is not synonymous with POTS and is a separate problem, but NMS can lead to similar symptoms of orthostatic intolerance particularly in the immediately pre-syncopal phase.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationUp to 30% of POTS patients may experience syncope, and these patients may have both NMS and POTS, because these disorders can occur together.
“However, up to 30% of POTS patients may experience syncope, and these patients may have both NMS and POTS, because these disorders can occur together (9,65).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [9] Raj, 2006, The postural tachycardia syndrome (POTS): pathophysiology, diagnosis & management, Indian Pacing Electrophysiol J
- cites [65] Ojha, 2011, Comorbidities in pediatric patients with postural orthostatic tachycardia syndrome, J Pediatr source
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenSinus tachycardia is usually a normal physiological response to conditions in which the sympathetic nervous system is activated and the parasympathetic nervous system is inhibited, such as exercise, fever/infection, anemia, anxiety, and pain.
“Sinus tachycardia is usually a normal physiological response to conditions in which the sympathetic nervous system is activated and the parasympathetic nervous system is inhibited, such as exercise, fever/ infection, anemia, anxiety, and pain.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
Premisenone givenOrthostatic tachycardia alone is not sufficient to diagnose POTS; other diagnostic criteria apply, and other syndromes and intrinsic cardiac abnormalities must be excluded.
“Orthostatic tachycardia alone is not sufficient to diagnose POTS; other diagnostic criteria apply, and other syndromes and intrinsic cardiac abnormalities must be excluded.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Premisenone givenThe tachycardia of POTS is a sinus tachycardia.
“The tachycardia of POTS is a sinus tachycardia.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenSimilarly to patients with POTS, patients with neurogenic orthostatic hypotension can also complain of orthostatic intolerance.
“Similarly to patients with POTS, patients with neurogenic orthostatic hypotension (NOH) can also complain of orthostatic intolerance.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationEvaluation for pheochromocytoma is best made by measuring plasma metanephrines.
“Evaluation for pheochromocytoma is best made by measuring plasma metanephrines (67).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [67] Lenders, 2002, Biochemical diagnosis of pheochromocytoma: which test is best?, JAMA source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisereasoningAcute or chronic hypovolemia may be associated with orthostatic sinus tachycardia, with or without accompanying orthostatic hypotension, as stroke volume falls and HR increases to maintain cardiac output and oxygen delivery to tissue.
“Acute or chronic hypovolemia may be associated with orthostatic sinus tachycardia, with or without accompanying orthostatic hypotension, as stroke volume falls and HR increases to maintain cardiac output and oxygen delivery to tissue.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationOnly a single case report has been described of a woman with POTS who had both symptoms and urodynamic evidence of detrusor hyperreflexia; other data providing objective evidence of urinary dysfunction in POTS patients are lacking.
“Only a single case report has been described of a woman with POTS who had both symptoms and urodynamic evidence of detrusor hyperreflexia (91); other data providing objective evidence of urinary dysfunction in POTS patients are lacking.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [91] O'Leary, 2002, Neurovesical dysfunction in postural tachycardia syndrome (POTS), Int Urogynecol J Pelvic Floor Dysfunct source
May combine two claims.
InterpretationreasoningJoint hypermobility may not be pathophysiologically important for the development of orthostatic intolerance in POTS patients; rather it may be another comorbid condition that occurs in patients with chronic functional disorders.
“This suggests that joint hypermobility may not be pathophysiologically important for the development of orthostatic intolerance in POTS patients; rather it may be another comorbid condition that occurs in patients with chronic functional disorders (71).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [71] Chelimsky, 2016, Benign joint hypermobility minimally impacts autonomic abnormalities in pediatric subjects with chronic functional pain disorders, J Pediatr source
May combine two claims.
PremisecitationA frequently described comorbidity in POTS patients is migraine, as well as other chronic headache types.
“A frequently described comorbidity in POTS patients is migraine, as well as other chronic headache types (6,65,72,73).”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [6] Thieben, 2007, Postural orthostatic tachycardia syndrome: the Mayo clinic experience, Mayo Clin Proc source
- cites [65] Ojha, 2011, Comorbidities in pediatric patients with postural orthostatic tachycardia syndrome, J Pediatr source
- cites [72] Mack, 2010, Orthostatic intolerance and the headache patient, Semin Pediatr Neurol source
- cites [73] Qubty, 2016, Dizziness and orthostatic intolerance in pediatric headache patients, Semin Pediatr Neurol source
May combine two claims.
InterpretationcitationAn exaggerated sympathetic vasoconstrictor response during the Valsalva maneuver or the presence of orthostatic hypertension may suggest hyperadrenergic POTS.
“An exaggerated sympathetic vasoconstrictor response during the Valsalva maneuver or the presence of orthostatic hypertension may suggest hyperadrenergic POTS (46).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [46] Shibao, 2005, Hyperadrenergic postural tachycardia syndrome in mast cell activation disorders, Hypertension source
May combine two claims.
PremisecitationExercise therapy is most successful when the program is supervised by experienced trainers or physical therapists that understand the pathophysiology of POTS, though it has also been demonstrated to be highly effective when administered in a community setting.
“Exercise therapy is most successful when the program is supervised by experienced trainers or physical therapists that understand the pathophysiology of POTS, though it has also been demonstrated to be highly effective when administered in a community setting (64).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [64] George, 2016, The international POTS registry: Evaluating the efficacy of an exercise training intervention in a community setting, Heart Rhythm source
May combine two claims.
PremisecitationThese measures increase venous return and lessen orthostatic tachycardia.
“These measures increase venous return and lessen orthostatic tachycardia (105).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [105] Smit, 2004, Use of lower abdominal compression to combat orthostatic hypotension in patients with autonomic dysfunction, Clin Auton Res source
May combine two claims.
PremisecitationThis effect, however, is transient, and ultimately results in a net loss of plasma volume following the infusion.
“This effect, however, is transient, and ultimately results in a net loss of plasma volume following the infusion (104).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [104] Heer, 1992, Effects of head-down tilt and saline loading on body weight, fluid, and electrolyte homeostasis in man, Acta Physiol Scand Suppl
Probably not a substantial claim: may not pass S4 (based).
Interpretationnone givenNonorthostatic comorbid symptoms and conditions may persist even after the orthostatic tachycardia is treated.
“Nonorthostatic comorbid symptoms and conditions may persist even after the orthostatic tachycardia is treated.”
Quote in the paperNot a substantial claim- Rests on an assumption: Many symptoms occur independently of POTS, and others persist even after the resolution of postural intolerance.
Probably not a substantial claim: may not pass S4 (based). May combine two claims.
Interpretationnone givenPOTS is a heterogeneous disorder with many overlapping symptoms and pathophysiological mechanisms.
“POTS is a heterogeneous disorder with many overlapping symptoms and pathophysiological mechanisms.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningThe most effective treatment for POTS is a regular, structured, progressive exercise regimen, enhanced by volume expansion with ingested salt and fluids.
“The most effective treatment is a regular, structured, progressive exercise regimen, enhanced by volume expansion with ingested salt and fluids.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationConcussion has been associated with development of POTS, and there is a relatively high rate of POTS in patients with persistent post-concussive syndrome.
“Concussion has also been associated with development of POTS, and there is a relatively high rate of POTS in patients with persistent post-concussive syndrome.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningEven when deconditioning does not seem to be a large factor in the development of POTS, exercise training can still be useful in its treatment by improving fitness and reducing pain and hypervigilance through well-defined neural mechanisms.
“Even in cases where deconditioning does not seem to be a large factor in the development of POTS, it can still be useful in its treatment by improving fitness, and reducing pain and hypervigilance through welldefined neural mechanisms.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationSport-related concussion has been reported to affect postural stability and neurocognitive function.
“Sport-related concussion has been reported to affect postural stability as well as neurocognitive function(74).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [74] Guskiewicz, 2001, Postural stability assessment following concussion: one piece of the puzzle, Clin J Sport Med source
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenStandard evaluations for POTS include laboratory, physical examination, and simple stand test.
“Standard evaluations include laboratory, physical examination, and simple stand test.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Interpretationnone givenThe most common demographic of POTS is young, previously active women, and frequently an identifiable event such as illness, pregnancy, or surgery precedes symptom onset and precipitates withdrawal of activity or frank bedrest.
“The most common demographic is young, previously active women, and frequently, there is an identifiable event (such as illness, pregnancy, or surgery) that precedes symptom onset and precipitates withdrawal of activity or frank bedrest.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Interpretationnone givenIntractable migraines often lead to physical inactivity, which may exacerbate orthostatic intolerance, and increased sympathetic activity associated with POTS may contribute to increased frequency of headaches.
“Intractable migraines often lead to physical inactivity, which may exacerbate orthostatic intolerance, and conversely, the increased sympathetic activity associated with POTS may contribute to increased frequency of headaches.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationPerceptual amplification and hypervigilance are phenomena described in chronic pain conditions like fibromyalgia.
“Perceptual amplification and hypervigilance are phenomena described in chronic pain conditions, like fibromyalgia.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites (76)(77)(78)
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
Interpretationnone givenPOTS cardinal symptoms occur with standing and improve with sitting or lying, but patients often have other chronic symptoms and comorbidities that cannot be physiologically explained by orthostatic intolerance or tachycardia.
“Although the cardinal symptoms of POTS occur with standing and improve with sitting or lying, patients often relate other chronic symptoms and comorbidities that cannot physiologically be explained by orthostatic intolerance or tachycardia.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationPerceptual amplification and hypervigilance are associated with increased sensitivity and aversion toward somatic signals, tactile stimuli, and pain, and an increased propensity to report sensations that others might ignore.
“They are associated with an increased sensitivity and aversion toward somatic signals, tactile stimuli, and pain, with an increased propensity to report sensations that others might ignore(76)(77)(78).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites (76)(77)(78)
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
PremisecitationDroxidopa has been studied in a small number of POTS patients; although it may have helped to improve some symptoms of orthostatic intolerance, it did not significantly improve quality of life.
“Droxidopa has been studied in a small number of POTS patients; although it may have helped to improve some symptoms of orthostatic intolerance, it did not significantly improve quality of life (111).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [111] Ruzieh, 2017, Droxidopa in the treatment of postural orthostatic tachycardia syndrome, Am J Ther source
May combine two claims.
Interpretationnone givenThe conditions associated with POTS are not core features of, nor synonymous with, POTS; they are syndromes that may occur together with POTS.
“Specifically, the following described conditions are not core features of, nor are they synonymous with, POTS.Rather, these are syndromes that may occur together with POTS (Figure4).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Interpretationnone givenOther nonpharmacological and pharmacological interventions may be supplemental in POTS treatment.
“Other nonpharmacological and pharmacological interventions may be supplemental.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationAlthough anxiety is commonly described in POTS, the excessive tachycardia is not simply a physiological manifestation of anxiety.
“Although anxiety is a commonly described in POTS, the excessive tachycardia is not simply a physiological manifestation of anxiety(80).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [80] Masuki, 2007, Excessive heart rate response to orthostatic stress in postural tachycardia syndrome is not caused by anxiety, J Appl Physiol source
May combine two claims.
InterpretationcitationThe resolution of POTS often runs parallel with the resolution of postconcussive syndrome, likely reflecting the patient's return to physical activity.
“The resolution of POTS often runs parallel with the resolution of postconcussive syndrome (75) likely reflecting the patient's return to physical activity.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [75] Heyer, 2016, Orthostatic intolerance and autonomic dysfunction in youth with persistent postconcussion symptoms: a head-upright tilt table study, Clin J Sport Med source
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenAn active stand test is a simple evaluation for POTS and orthostatic hypotension that can be done at the bedside or in the clinic with only an automated or manual BP cuff.
“An active stand test is a simple evaluation for POTS (and orthostatic hypotension) that can be done at the bedside or in the clinic with only an automated or manual BP cuff.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationSpecific data supporting psychological therapy in POTS are lacking, but there is a 2016 case report demonstrating significant decrease in POTS-related functional impairment in a woman treated with cognitive behavioral therapy.
“Specific data supporting psychological therapy in POTS are lacking, but there is a 2016 case report demonstrating significant decrease in POTS-related functional impairment in a woman treated with cognitive behavioral therapy (116).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [116] Ralston, 2016, Symptom discrimination and habituation: a case study of behavioral treatment for postural orthostatic tachycardia syndrome (POTS), Behav Med source
Classified as probably not a substantial claim. May combine two claims.
Interpretationnone givenThe unifying characteristics of POTS are excessive tachycardia in the upright position, without orthostatic hypotension, and with associated presyncopal symptoms and orthostatic intolerance.
“The unifying characteristics are excessive tachycardia in the upright position, without orthostatic hypotension, and with associated presyncopal symptoms and orthostatic intolerance.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S4 (based).
InterpretationreasoningBehavioral and cognitive therapy may help POTS patients with significant associated symptoms such as anxiety, hypervigilance, and brain fog.
“These symptoms can be challenging to treat, and behavioral and cognitive therapy may help patients with significant associated symptoms such as anxiety, hypervigilance, and brain fog.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
A period of enforced bedrest is often a common theme in patients with POTS, even those who have previously been quite active.
“Indeed, a period of enforced bedrest is often a common theme in patients with POTS, even those who have previously been quite active.”
The paper relies on this without support.
In many cases, patients with POTS relate a healthy and active premorbid state; some are competitive athletes or high-performing high school or college students before developing POTS.
“In many cases, patients relate a healthy and active premorbid state; some are competitive athletes or high-performing high school or college students before developing POTS.”
The paper relies on this without support.
POTS is quite rare after menopause.
“It is our experience that POTS is quite rare after menopause, though explanations for this age specificity are unsatisfying.”
The authors state this as an assumption.
Underlying hormonal changes, presumably relating to the balance between testosterone and estrogen, play a role in the age specificity of POTS.
“The underlying hormonal changes, presumably relating to the balance between testosterone and estrogen, must be playing a role.”
The paper relies on this without support.
The current epidemiology of POTS is not known.
“The current epidemiology is not known, but due to increased awareness of the syndrome, the prevalence of POTS may have increased over the past 2 decades.”
The paper relies on this without support.
The pathophysiology and mechanisms of POTS are not well understood.
“This is a heterogeneous disorder, the pathophysiology and mechanisms of which are not well understood.”
The paper relies on this without support.
These tests (provocative medications during HUT) unmask NMS in addition to evoking syncope in several other conditions, including many normal individuals, and are very nonspecific.
“In actuality, these tests unmask NMS in addition to evoking syncope in several other conditions, including many normal individuals, and recent studies have shown these tests to be very nonspecific.”
The paper relies on this without support.
Environmental heat, prolonged upright posture, prolonged fasting, excessive alcohol intake, straining, or vasodilatory medications will exacerbate orthostatic intolerance.
“Environmental heat, prolonged upright posture, prolonged fasting, excessive alcohol intake, straining (such as during urination or bowel movements), or vasodilatory medications will exacerbate orthostatic intolerance and should be avoided when possible.”
The paper relies on this without support.
Chronic fatigue and fibromyalgia often lead to a reduction in physical activity, subsequent deconditioning, and exacerbation of orthostatic intolerance.
“Furthermore, chronic fatigue and fibromyalgia often lead to a reduction in physical activity, subsequent deconditioning, and exacerbation of orthostatic intolerance.”
The paper relies on this without support.
Patients with hyperadrenergic POTS may have elevated NE levels (typically >600 to 1,000 pg/ml).
“Patients with hyperadrenergic POTS may have elevated NE levels (typically >600 to 1,000 pg/ml).”
The paper relies on this without support.
Plasma tryptase may be elevated in these individuals during symptomatic episodes.
“Plasma tryptase may be elevated in these individuals during symptomatic episodes.”
The paper relies on this without support.
N-methylhistamine >230 mg/g creatinine in a 4-h urine collection immediately following a spontaneous event would also be suggestive of this disorder.
“N-methylhistamine >230 mg/g creatinine in a 4-h urine collection immediately following a spontaneous event would also be suggestive of this disorder.”
The paper relies on this without support.
In the majority of cases, POTS can be diagnosed and managed by primary care physicians.
“In the majority of cases, POTS can be diagnosed and managed by primary care physicians.”
The paper relies on this without support.
POTS often can be managed by nonpharmacological measures alone.
“POTS often can be managed by nonpharmacological measures alone.”
The paper relies on this without support.
These strategies can help increase blood volume and minimize orthostatic symptoms.
“These strategies can help increase blood volume and minimize orthostatic symptoms.”
The paper relies on this without support.
In MCAD, inappropriate release of histamine and other mast cell mediators in response to physical activity or orthostatic stress may lead to orthostatic tachycardia.
“In mast cell activation disorder (MCAD), inappropriate release of histamine and other mast cell mediators in response to physical activity or orthostatic stress may lead to orthostatic tachycardia.”
The paper relies on this without support.
MCAD patients may have POTS with hyperadrenergic features (increased HR and BP with standing).
“MCAD patients may have POTS with hyperadrenergic features (increased HR and BP with standing).”
The paper relies on this without support.
Abrupt withdrawal of beta-blockers or central sympatholytic agents such as clonidine may cause rebound tachycardia.
“Abrupt withdrawal of certain medications such as beta-blockers or central sympatholytic agents such as clonidine, may also cause rebound tachycardia.”
The paper relies on this without support.
Many symptoms occur independently of POTS, and others persist even after the resolution of postural intolerance.
“Many symptoms occur independently of POTS, and others persist even after the resolution of postural intolerance.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Conflicting adolescent heart-rate threshold
MinorThe prose says the heart-rate increment must exceed 40 beats/min for patients under 20, whereas Figure 1 says an increment of at least 40 bpm qualifies for ages 12 to 19. They disagree at exactly 40 bpm.
“in patients under 20 years of age, the HR increment with upright posture should exceed 40 beats/min”
“or ≥40 bpm in individuals 12 to 19 years of age”
Conflicting criteria for orthostatic hypotension
MinorThe text defines orthostatic hypotension as a systolic drop of at least 20 mm Hg and/or a diastolic drop of at least 10 mm Hg. Figure 1 instead excludes only a systolic drop greater than 20 mm Hg. The definitions disagree for a diastolic-only drop and for a systolic drop of exactly 20 mm Hg, affecting who meets the stated POTS criteria.
“in the absence of orthostatic hypotension (a decrease in systolic blood pressure (BP) of 20 or more mm Hg and/or decrease in diastolic BP of 10 or more mm Hg)”
“2) the absence of orthostatic hypotension (>20 mm Hg drop in systolic blood pressure);”
Cites
Freeman, R., Wieling, W., Axelrod, F. B., Benditt, D. G., Benarroch, E., Biaggioni, I., Cheshire, W. P., Chelimsky, T., Cortelli, P., Gibbons, C. H., et al. (2011) · Clinical Autonomic Research · doi:10.1007/s10286-011-0119-5 · Cited by 1,697 · see citing works
Self-citationFreeman, R., Wieling, W., Axelrod, F. B., Benditt, D. G., Benarroch, E., Biaggioni, I., Cheshire, W. P., Chelimsky, T., Cortelli, P., Gibbons, C. H., et al. (2011) · Autonomic Neuroscience · doi:10.1016/j.autneu.2011.02.004 · Cited by 1,243 · see citing works
Self-citationBiochemical Diagnosis of Pheochromocytoma: Which Test Is Best?
Lenders, J. W. M., Pacak, K., Walther, M. M., Linehan, W. M., Mannelli, M., Friberg, P., Keiser, H. R., Goldstein, D. S., & Eisenhofer, G. (2002) · JAMA · doi:10.1001/jama.287.11.1427 · Cited by 1,134 · see citing works
Sheldon, R. S., Grubb, B. P., Olshansky, B., Shen, W.-K., Calkins, H., Brignole, M., Raj, S. R., Krahn, A. D., Morillo, C. A., Stewart, J. M., et al. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.03.029 · Cited by 1,013 · see citing works
Orthostatic intolerance after spaceflight
Buckey, J. C., Lane, L. D., Levine, B. D., Watenpaugh, D. E., Wright, S. J., Moore, W. E., Gaffney, F. A., & Blomqvist, C. G. (1996) · Journal of Applied Physiology · doi:10.1152/jappl.1996.81.1.7 · Cited by 596 · see citing works
Self-citationHuman Circulation: Regulation During Physical Stress
Iatridis, P. G. (1987) · JAMA · doi:10.1001/jama.1987.03400220116052 · Cited by 533 · see citing works
Postural orthostatic tachycardia syndrome: the Mayo clinic experience
Thieben, M. J., Sandroni, P., Sletten, D. M., Benrud-Larson, L. M., Fealey, R. D., Vernino, S., Low, P. A., Lennon, V. A., & Shen, W.-K. (2007) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)61027-6 · Cited by 516 · see citing works
Self-citationCardiac atrophy after bed rest and spaceflight
Perhonen, M. A., Franco, F., Lane, L. D., Buckey, J. C., Blomqvist, C. G., Zerwekh, J. E., Peshock, R. M., Weatherall, P. T., & Levine, B. D. (2001) · Journal of Applied Physiology · doi:10.1152/jappl.2001.91.2.645 · Cited by 494 · see citing works
Self-citationPalermo, T. M., Eccleston, C., Lewandowski, A. S., de C. Williams, A. C., & Morley, S. (2010) · Pain · doi:10.1016/j.pain.2009.10.004 · Cited by 489 · see citing works
Gibbons, C. H., Schmidt, P., Biaggioni, I., Frazier-Mills, C., Freeman, R., Isaacson, S., Karabin, B., Kuritzky, L., Lew, M., Low, P., et al. (2017) · Journal of Neurology · doi:10.1007/s00415-016-8375-x · Cited by 455 · see citing works
Self-citationManagement of Vasovagal Syncope: Controlling or Aborting Faints by Leg Crossing and Muscle Tensing
Krediet, C. T. P., van Dijk, N., Linzer, M., van Lieshout, J. J., & Wieling, W. (2002) · Circulation · doi:10.1161/01.cir.0000030939.12646.8f · Cited by 372 · see citing works
Generalized hypervigilance in fibromyalgia: evidence of perceptual amplification
McDermid, A. J., Rollman, G. B., & McCain, G. A. (1996) · Pain · doi:10.1016/0304-3959(96)03059-x · Cited by 371 · see citing works
Cardiac Atrophy After Bed-Rest Deconditioning: A Nonneural Mechanism for Orthostatic Intolerance
Levine, B. D., Zuckerman, J. H., & Pawelczyk, J. A. (1997) · Circulation · doi:10.1161/01.cir.96.2.517 · Cited by 371 · see citing works
Self-citationPostural tachycardia syndrome: a heterogeneous and multifactorial disorder
Benarroch, E. E. (2012) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2012.08.013 · Cited by 370 · see citing works
Time course of loss of adaptations after stopping prolonged intense endurance training
Coyle, E. F., Martin, W. H., Sinacore, D. R., Joyner, M. J., Hagberg, J. M., & Holloszy, J. O. (1984) · Journal of Applied Physiology · doi:10.1152/jappl.1984.57.6.1857 · Cited by 364 · see citing works
Postural tachycardia syndrome (POTS)
LOW, P. A., SANDRONI, P., JOYNER, M., & SHEN, W. (2009) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2008.01407.x · Cited by 358 · see citing works
Postural stability assessment following concussion: one piece of the puzzle
Guskiewicz, K. M. (2001) · Clinical Journal of Sport Medicine · doi:10.1097/00042752-200107000-00009 · Cited by 343 · see citing works
Cardiac origins of the postural orthostatic tachycardia syndrome
Fu, Q., VanGundy, T. B., Galbreath, M. M., Shibata, S., Jain, M., Hastings, J. L., Bhella, P. S., & Levine, B. D. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.02.043 · Cited by 329 · see citing works
Self-citationHemodynamic Response to the Upright Posture
Smith, J. J., Porth, C. M., & Erickson, M. (1994) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1994.tb04977.x · Cited by 320 · see citing works
Postural Tachycardia Syndrome (POTS)
Raj, S. R. (2013) · Circulation · doi:10.1161/circulationaha.112.144501 · Cited by 320 · see citing works
Cardiovascular Adjustments to Gravitational Stress
Blomqvist, C. G., & STONE, H. L. (1983) · Comprehensive physiology · doi:10.1002/cphy.cp020328 · Cited by 297 · see citing works
The epidemic of orthostatic tachycardia and orthostatic intolerance
Robertson, D. (1999) · The American Journal of the Medical Sciences · doi:10.1016/s0002-9629(15)40480-x · Cited by 293 · see citing works
Autoimmune Basis for Postural Tachycardia Syndrome
Li, H., Yu, X., Liles, C., Khan, M., Vanderlinde‐Wood, M., Galloway, A., Zillner, C., Benbrook, A., Reim, S., Collier, D., et al. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.113.000755 · Cited by 255 · see citing works
Bungo, M. W., Charles, J. B., & Johnson, P. C. (1985) · PubMed · Cited by 250 · see citing works
Subnormal norepinephrine release relates to presyncope in astronauts after spaceflight
Fritsch-Yelle, J. M., Whitson, P. A., Bondar, R. L., & Brown, T. E. (1996) · Journal of Applied Physiology · doi:10.1152/jappl.1996.81.5.2134 · Cited by 238 · see citing works
Waters, W. W., Ziegler, M. G., & Meck, J. V. (2002) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00544.2001 · Cited by 232 · see citing works
Spaceflight alters autonomic regulation of arterial pressure in humans
Fritsch-Yelle, J. M., Charles, J. B., Jones, M. M., Beightol, L. A., & Eckberg, D. L. (1994) · Journal of Applied Physiology · doi:10.1152/jappl.1994.77.4.1776 · Cited by 226 · see citing works
Hyperadrenergic Postural Tachycardia Syndrome in Mast Cell Activation Disorders
Shibao, C., Arzubiaga, C., Roberts, L. J., Raj, S., Black, B., Harris, P., & Biaggioni, I. (2005) · Hypertension · doi:10.1161/01.hyp.0000158259.68614.40 · Cited by 220 · see citing works
Hemodynamics of orthostatic intolerance: implications for gender differences
Fu, Q., Arbab‐Zadeh, A., Perhonen, M. A., Zhang, R., Zuckerman, J. H., & Levine, B. D. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00735.2002 · Cited by 220 · see citing works
Self-citationHuman muscle sympathetic neural and haemodynamic responses to tilt following spaceflight
Levine, B. D., Pawelczyk, J. A., Ertl, A. C., Cox, J. F., Zuckerman, J. H., Diedrich, A., Biaggioni, I., Ray, C. A., Smith, M. L., Iwase, S., et al. (2002) · The Journal of Physiology · doi:10.1113/jphysiol.2001.012575 · Cited by 191 · see citing works
Self-citation(2006) · PubMed · Cited by 190 · see citing works
Cardiac atrophy in women following bed rest
Dorfman, T. A., Levine, B. D., Tillery, T., Peshock, R. M., Hastings, J. L., Schneider, S. M., Macias, B. R., Biolo, G., & Hargens, A. R. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01162.2006 · Cited by 189 · see citing works
Self-citationEffects of gender and hypovolemia on sympathetic neural responses to orthostatic stress
Fu, Q., Witkowski, S., Okazaki, K., & Levine, B. D. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00013.2005 · Cited by 186 · see citing works
Self-citationFu, Q., VanGundy, T. B., Shibata, S., Auchus, R. J., Williams, G. H., & Levine, B. D. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.172262 · Cited by 175 · see citing works
Self-citationAcetylcholinesterase inhibition improves tachycardia in postural tachycardia syndrome
Raj, S. R., Black, B. K., Biaggioni, I., Harris, P. A., & Robertson, D. (2005) · Circulation · doi:10.1161/circulationaha.104.497594 · Cited by 171 · see citing works
Streeten, D. H. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114878 · Cited by 170 · see citing works
Hollins, M., Harper, D., Gallagher, S., Owings, E. W., Lim, P. F., Miller, V. E., Siddiqi, M., & Maixner, W. D. (2009) · Pain · doi:10.1016/j.pain.2008.10.003 · Cited by 165 · see citing works
Hirshoren, N., Tzoran, I., Makrienko, I., Edoute, Y., Plawner, M. M., Itskovitz‐Eldor, J., & Jacob, G. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.4.8406 · Cited by 165 · see citing works
Wooley, C. F. (1976) · Circulation · doi:10.1161/01.cir.53.5.749 · Cited by 162 · see citing works
Postural tachycardia syndrome: beyond orthostatic intolerance
Garland, E. M., Celedonio, J. E., & Raj, S. R. (2015) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-015-0583-8 · Cited by 160 · see citing works
Maximal exercise performance after adaptation to microgravity
Levine, B. D., Lane, L. D., Watenpaugh, D. E., Gaffney, F. A., Buckey, J. C., & Blomqvist, C. G. (1996) · Journal of Applied Physiology · doi:10.1152/jappl.1996.81.2.686 · Cited by 156 · see citing works
Self-citationSmit, A. J., Wieling, W., Fujimura, J., Denq, J., Opfer-Gehrking, T., Akarriou, M., Karemaker, J., & Low, P. (2004) · Clinical Autonomic Research · doi:10.1007/s10286-004-0187-x · Cited by 153 · see citing works
Deterioration of Left Ventricular Chamber Performance After Bed Rest
Perhonen, M. A., Zuckerman, J. H., & Levine, B. D. (2001) · Circulation · doi:10.1161/01.cir.103.14.1851 · Cited by 149 · see citing works
Self-citationMenstrual cycle effects on sympathetic neural responses to upright tilt
Fu, Q., Okazaki, K., Shibata, S., Shook, R. P., VanGunday, T. B., Galbreath, M. M., Reelick, M. F., & Levine, B. D. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2008.168468 · Cited by 144 · see citing works
Self-citationWhat is brain fog? An evaluation of the symptom in postural tachycardia syndrome
Ross, A. J., Medow, M. S., Rowe, P. C., & Stewart, J. M. (2013) · Clinical Autonomic Research · doi:10.1007/s10286-013-0212-z · Cited by 141 · see citing works
Stewart, J. M. (2002) · Circulation · doi:10.1161/01.cir.0000016348.55378.c4 · Cited by 138 · see citing works
Comorbidities in pediatric patients with postural orthostatic tachycardia syndrome
Ojha, A., Chelimsky, T. C., & Chelimsky, G. (2011) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2010.07.005 · Cited by 131 · see citing works
Plash, W. B., Diedrich, A., Biaggioni, I., Garland, E. M., Paranjape, S. Y., Black, B. K., Dupont, W. D., & Raj, S. R. (2013) · Clinical Science · doi:10.1042/cs20120276 · Cited by 128 · see citing works
George, S. A., Bivens, T. B., Howden, E. J., Saleem, Y., Galbreath, M. M., Hendrickson, D., Fu, Q., & Levine, B. D. (2016) · Heart Rhythm · doi:10.1016/j.hrthm.2015.12.012 · Cited by 127 · see citing works
Self-citationMarkham, D. W., Fu, Q., Palmer, M. D., Drazner, M. H., Meyer, D. M., Bethea, B. T., Hastings, J. L., Fujimoto, N., Shibata, S., & Levine, B. D. (2012) · Circulation Heart Failure · doi:10.1161/circheartfailure.112.969873 · Cited by 120 · see citing works
Self-citationAdolescent Fatigue, POTS, and Recovery: A Guide for Clinicians
Kizilbash, S. J., Ahrens, S. P., Bruce, B. K., Chelimsky, G., Driscoll, S. W., Harbeck-Weber, C., Lloyd, R. M., Mack, K. J., Nelson, D. E., Ninis, N., et al. (2014) · Current Problems in Pediatric and Adolescent Health Care · doi:10.1016/j.cppeds.2013.12.014 · Cited by 120 · see citing works
Gaffney, F. A., Nixon, J. V., Karlsson, E. S., Campbell, W., Dowdey, A. B. C., & Blomqvist, C. G. (1985) · The American Journal of Cardiology · doi:10.1016/0002-9149(85)91025-2 · Cited by 113 · see citing works
Shibata, S., Fu, Q., Bivens, T. B., Hastings, J. L., Wang, W., & Levine, B. D. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2012.233858 · Cited by 109 · see citing works
Self-citationPyridostigmine in the treatment of postural orthostatic tachycardia: a single-center experience
KANJWAL, K., KARABIN, B., SHEIKH, M., ELMER, L., KANJWAL, Y., SAEED, B., & GRUBB, B. P. (2011) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2011.03047.x · Cited by 106 · cited 1× · see citing works
“Pyridostigmine (a cholinergic agonist that works by inhibiting acetylcholinesterase) 30 to 60 mg 3 times a day can increase parasympathetic autonomic tone (107,108) and has a lower risk of hypertension compared with other medications.”
The Postural Tachycardia Syndrome
Medow, M. S., & Stewart, J. M. (2007) · Cardiology in Review · doi:10.1097/01.crd.0000233768.68421.40 · Cited by 105 · see citing works
Single centre experience of ivabradine in postural orthostatic tachycardia syndrome
McDonald, C., Frith, J., & Newton, J. L. (2011) · Europace · doi:10.1093/europace/euq390 · Cited by 105 · see citing works
Nonpharmacological treatment of reflex syncope
Wieling, W., Colman, N., Krediet, C. T. P., & Freeman, R. (2004) · Clinical Autonomic Research · doi:10.1007/s10286-004-1009-x · Cited by 102 · see citing works
Ehlers–Danlos Syndrome and Postural Tachycardia Syndrome: A relationship study
Wallman, D., Weinberg, J., & Hohler, A. D. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.03.002 · Cited by 100 · see citing works
Structural and Functional Small Fiber Abnormalities in the Neuropathic Postural Tachycardia Syndrome
Gibbons, C. H., Bonyhay, I., Benson, A., Wang, N., & Freeman, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0084716 · Cited by 99 · cited 2× · see citing works
“In addition to reduced distal sudomotor function, they have also been shown to have lower supine and standing HRs, and less prominent overshoot during release of Valsalva when compared with other POTS patients (6,35).”
Regulation of muscle sympathetic nerve activity after bed rest deconditioning
Pawelczyk, J. A., Zuckerman, J. H., Blomqvist, C. G., & Levine, B. D. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.280.5.h2230 · Cited by 92 · see citing works
Self-citationMasuki, S., Eisenach, J. H., Johnson, C. P., Dietz, N. M., Benrud-Larson, L. M., Schrage, W. G., Curry, T. B., Sandroni, P., Low, P. A., & Joyner, M. J. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00927.2006 · Cited by 91 · see citing works
POTS versus deconditioning: the same or different?
Joyner, M. J., & Masuki, S. (2008) · Clinical Autonomic Research · doi:10.1007/s10286-008-0487-7 · Cited by 90 · see citing works
Neurohumoral and haemodynamic profile in postural tachycardia and chronic fatigue syndromes
Okamoto, L. E., Raj, S. R., Peltier, A., Gamboa, A., Shibao, C., Diedrich, A., Black, B. K., Robertson, D., & Biaggioni, I. (2012) · Clinical Science · doi:10.1042/cs20110200 · Cited by 89 · see citing works
Cornwell, W. K., Tarumi, T., Stickford, A. S. L., Lawley, J. S., Roberts, M. A., Parker, R. S., Fitzsimmons, C., Kibe, J., Ayers, C. R., Markham, D. W., et al. (2015) · Circulation · doi:10.1161/circulationaha.115.017647 · Cited by 81 · see citing works
Self-citationBlood Volume Perturbations in the Postural Tachycardia Syndrome
Raj, S. R., & Robertson, D. (2007) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e318063c6c0 · Cited by 80 · see citing works
Vasomotor sympathetic neural control is maintained during sustained upright posture in humans
Fu, Q., Shook, R. P., Okazaki, K., Hastings, J. L., Shibata, S., Conner, C. L., Palmer, M. D., & Levine, B. D. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.118158 · Cited by 80 · see citing works
Self-citationSmall-fiber neuropathy with cardiac denervation in postural tachycardia syndrome
Haensch, C., Tosch, M., Katona, I., Weis, J., & Isenmann, S. (2014) · Muscle & Nerve · doi:10.1002/mus.24245 · Cited by 79 · see citing works
The clinical approach to autonomic failure in neurological disorders
Benarroch, E. E. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.88 · Cited by 71 · see citing works
Effects of Norepinephrine Reuptake Inhibition on Postural Tachycardia Syndrome
Green, E. A., Raj, V., Shibao, C. A., Biaggioni, I., Black, B. K., Dupont, W. D., Robertson, D., & Raj, S. R. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000395 · Cited by 64 · see citing works
Heyer, G. L., Fischer, A., Wilson, J., MacDonald, J., Cribbs, S., Ravindran, R., Pommering, T. L., & Cuff, S. (2016) · Clinical Journal of Sport Medicine · doi:10.1097/jsm.0000000000000183 · Cited by 64 · see citing works
Loavenbruck, A., Iturrino, J., Singer, W., Sletten, D. M., Low, P. A., Zinsmeister, A. R., & Bharucha, A. E. (2015) · Neurogastroenterology & Motility · doi:10.1111/nmo.12480 · Cited by 63 · see citing works
Fu, Q., VanGundy, T. B., Shibata, S., Auchus, R. J., Williams, G. H., & Levine, B. D. (2010) · Hypertension · doi:10.1161/hypertensionaha.110.151787 · Cited by 62 · see citing works
Self-citationSmall heart syndrome in patients with chronic fatigue syndrome
Miwa, K., & Fujita, M. (2008) · Clinical Cardiology · doi:10.1002/clc.20227 · Cited by 61 · see citing works
Stewart, J. M., Ocon, A. J., Clarke, D., Taneja, I., & Medow, M. S. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.127357 · Cited by 59 · see citing works
Epigenetic Modification of the Norepinephrine Transporter Gene in Postural Tachycardia Syndrome
Bayles, R., KN, H., Lambert, E., Baker, E. K., Agrotis, A., Guo, L., Jowett, J. B. M., Esler, M., Lambert, G., & El-Osta, A. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.244343 · Cited by 56 · see citing works
Diurnal variability in orthostatic tachycardia: implications for the postural tachycardia syndrome
Brewster, J. A., Garland, E. M., Biaggioni, I., Black, B. K., Ling, J. F., Shibao, C. A., Robertson, D., & Raj, S. R. (2012) · Clinical Science · doi:10.1042/cs20110077 · Cited by 56 · see citing works
Effects of exercise training on arterial-cardiac baroreflex function in POTS
Galbreath, M. M., Shibata, S., VanGundy, T. B., Okazaki, K., Fu, Q., & Levine, B. D. (2011) · Clinical Autonomic Research · doi:10.1007/s10286-010-0091-5 · Cited by 54 · see citing works
Self-citationChelimsky, G., Kovacic, K., Nugent, M., Mueller, A., Simpson, P., & Chelimsky, T. C. (2015) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2015.03.039 · Cited by 52 · see citing works
Neuronal and hormonal perturbations in postural tachycardia syndrome
Mar, P. L., & Raj, S. R. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00220 · Cited by 52 · see citing works
Gynecologic disorders and menstrual cycle lightheadedness in postural tachycardia syndrome
Peggs, K. J., Nguyen, H., Enayat, D., Keller, N. R., Al‐Hendy, A., & Raj, S. R. (2012) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2012.04.014 · Cited by 51 · see citing works
Orthostatic intolerance and the headache patient
Mack, K. J., Johnson, J. N., & Rowe, P. C. (2010) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2010.04.006 · Cited by 47 · see citing works
Gastrointestinal dysfunction in postural tachycardia syndrome
Wang, L. B., Culbertson, C. J., Deb, A., Morgenshtern, K., Huang, H., & Hohler, A. D. (2015) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2015.10.052 · Cited by 45 · see citing works
Gaffney, F. A. (1983) · CHEST Journal · doi:10.1378/chest.83.2_supplement.436 · Cited by 43 · see citing works
Droxidopa in the Treatment of Postural Orthostatic Tachycardia Syndrome
Ruzieh, M., Dasa, O., Pacenta, A., Karabin, B., & Grubb, B. (2017) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000000468 · Cited by 42 · see citing works
The genesis and presentation of anxiety in disorders of autonomic overexcitation
Owens, A. P., Low, D. A., Iodice, V., Critchley, H. D., & Mathias, C. J. (2017) · Autonomic Neuroscience · doi:10.1016/j.autneu.2016.10.004 · Cited by 41 · see citing works
Gaffney, F. A., Lane, L. B., Pettinger, W., & Blomqvist, C. G. (1983) · Chest · doi:10.1378/chest.83.2.436 · Cited by 36 · see citing works
Nitrate stimulated tilt table testing: a review of the literature
AERTS, A. J. J., & DENDALE, P. (2003) · Pacing and Clinical Electrophysiology · doi:10.1046/j.1460-9592.2003.t01-1-00222.x · Cited by 35 · see citing works
Cardiovascular adaptation to weightlessness.
Blomqvist, C. G. (1983) · PubMed · Cited by 35 · see citing works
Autonomic Testing in Women with Chronic Pelvic Pain
Chelimsky, G., Simpson, P., McCabe, N., Zhang, L., Chelimsky, T., & collaborative Debra Erickson Dr., K. P. D. (2016) · Journal of Urology · doi:10.1016/j.juro.2016.03.142 · Cited by 32 · see citing works
Barzilai, M., & Giris, J. (2015) · Rambam Maimonides Medical Journal · doi:10.5041/rmmj.10213 · Cited by 31 · see citing works
Kaufman, M. R., Chang‐Kit, L., Raj, S. R., Black, B. K., Milam, D. F., Reynolds, W. S., Biaggioni, I., Robertson, D., & Dmochowski, R. R. (2017) · Neurourology and Urodynamics · doi:10.1002/nau.22971 · Cited by 29 · see citing works
Kpaeyeh, J., Mar, P. L., Raj, V., Black, B. K., Arnold, A. C., Biaggioni, I., Shibao, C. A., Paranjape, S. Y., Dupont, W. D., Robertson, D., et al. (2014) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000221 · Cited by 29 · see citing works
Sleep disorders in patients with postural tachycardia syndrome
Miglis, M. G., Muppidi, S., Feakins, C., Fong, L., Prieto, T., & Jaradeh, S. (2016) · Clinical Autonomic Research · doi:10.1007/s10286-015-0331-9 · Cited by 25 · see citing works
Mar, P. L., Raj, V., Black, B. K., Biaggioni, I., Shibao, C. A., Paranjape, S. Y., Dupont, W. D., Robertson, D., & Raj, S. R. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881113512911 · Cited by 24 · see citing works
Moak, J. P., Fabian, R. R., Clarke, L. C., Hanumanthaiah, S., Desbiens, J., & Darbari, A. (2016) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000001150 · Cited by 24 · see citing works
Blomqvist, C. G. (1986) · Hypertension · doi:10.1161/01.hyp.8.8.722 · Cited by 23 · see citing works
Apollo space crew cardiovascular evaluations.
Hoffler, G. W., Wolthuis, R. A., & Rl, J. (1974) · PubMed · Cited by 22 · see citing works
Pengo, M. F., Higgins, S., Drakatos, P., Martin, K., Gall, N., Rossi, G. P., & Leschziner, G. (2015) · Sleep Medicine · doi:10.1016/j.sleep.2015.08.003 · Cited by 21 · see citing works
Clinical features of hyperadrenergic postural tachycardia syndrome in children
Zhang, Q., Chen, X., Li, J., & Du, J. (2014) · Pediatrics International · doi:10.1111/ped.12392 · Cited by 20 · see citing works
(1992) · PubMed · Cited by 19 · see citing works
Stickford, A. S. L., VanGundy, T. B., Levine, B. D., & Fu, Q. (2015) · The Journal of Physiology · doi:10.1113/jp270088 · Cited by 19 · see citing works
Self-citationEpidemiology and definition of inappropriate sinus tachycardia
Pellegrini, C. N., & Scheinman, M. M. (2016) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-015-0039-8 · Cited by 17 · see citing works
Moon, J., Lee, H. S., Byun, J.-I., Sunwoo, J.-S., Shin, J.-W., Lim, J.-A., Kim, T.-J., Shin, Y.-W., Lee, K.-J., Jeon, D., et al. (2016) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2016.01.011 · Cited by 17 · see citing works
Bagai, K., Peltier, A. C., Malow, B. A., Diedrich, A., Shibao, C. A., Black, B. K., Paranjape, S. Y., Orozco, C., Biaggioni, I., Robertson, D., et al. (2016) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.5806 · Cited by 17 · see citing works
Chelimsky, G., Kovacic, K., Simpson, P., Nugent, M., Basel, D., Banda, J., & Chelimsky, T. (2016) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2016.06.091 · Cited by 16 · see citing works
Cardiovascular adaptation to weightlessness
Blomqvist, C. G. (1983) · Medicine & Science in Sports & Exercise · doi:10.1249/00005768-198315050-00015 · Cited by 16 · see citing works
Ivancsits, S., Heider, A., Rüdiger, H. W., & Winker, R. (2003) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200302000-00002 · Cited by 15 · see citing works
Spacelab life sciences flight experiments
Gaffney, F. A. (1987) · Acta Astronautica · doi:10.1016/0094-5765(87)90074-9 · Cited by 13 · see citing works
Decreased orthostatic adrenergic reactivity in non-dipping postural tachycardia syndrome
Figueroa, J. J., Bott-Kitslaar, D. M., Mercado, J. A., Basford, J. R., Sandroni, P., Shen, W.-K., Sletten, D. M., Gehrking, T. L., Gehrking, J. A., Low, P. A., et al. (2014) · Autonomic Neuroscience · doi:10.1016/j.autneu.2014.06.003 · Cited by 12 · see citing works
Dizziness and orthostatic intolerance in pediatric headache patients
Qubty, W., & Kedia, S. (2016) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2016.01.004 · Cited by 12 · see citing works
Stimulant medication and postural orthostatic tachycardia syndrome: a tale of two cases
Cheshire, W. P. (2016) · Clinical Autonomic Research · doi:10.1007/s10286-016-0347-9 · Cited by 11 · see citing works
EDITORIAL: Why do young women (donors) faint?
Fu, Q., & Levine, B. D. (2010) · Transfusion · doi:10.1111/j.1537-2995.2010.02593.x · Cited by 10 · see citing works
Self-citationPrevalence of ganglionic AChR antibodies in postural tachycardia syndrome (POTS) (P1.276)
Vernino, S., Hopkins, S., Okamoto, L., Black, B., Dorminy, C., Paranjape, S., & Raj, S. (2015) · Neurology · doi:10.1212/wnl.84.14_supplement.p1.276 · Cited by 7 · see citing works
Self-citation(2015) · PubMed · Cited by 7 · see citing works
Li, J.-W., Liao, Y., Du, J.-B., & Zhang, Q.-Y. (2015) · Zhonghua yi xue za zhi · doi:10.3760/cma.j.issn.0376-2491.2015.36.009 · Cited by 7
Ralston, T. E., & Kanzler, K. E. (2016) · Behavioral Medicine · doi:10.1080/08964289.2014.977765 · Cited by 6 · see citing works
Neurovesical dysfunction in postural tachycardia syndrome (POTS)
O’Leary, M. L., Smith, C. P., Erickson, J. R., Eidelman, B. H., & Chancellor, M. B. (2002) · International Urogynecology Journal · doi:10.1007/s001920200030 · Cited by 4 · see citing works
Cornwell, W. K., Tarumi, T., Stickford, A., Kibe, J., Fitzsimmons, C., Moore, J., Roberts, M., Parker, R., Markham, D., Drazner, M., et al. (2015) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2015.01.160
Self-citationSleep Disorders in Patients with Postural Tachycardia Syndrome (P1.279)
Miglis, M., Muppidi, S., & Jaradeh, S. (2015) · Neurology · doi:10.1212/wnl.84.14_supplement.p1.279
Flagged first, then by citations
Research works printed but not linked: 2
- Vernino S, Bryarly M, Hopkins S, et al. The prevalence of galgnion AChR antibodies in postural tachycardia syndrome (POTS). Paper presented at: 27th International Symposium on the Autonomic Nervous System; November 3, 2016; San Diego, CA.
- Gibbons, 2011, Intense cardiovascular exercise as a treatment for postural tachycardia syndrome (POTS) (abstr), Neurology, 76, A264
Cited by
Sorted by citations
Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments
Yong, S. J. (2021) · Infectious Diseases · doi:10.1080/23744235.2021.1924397 · Cited by 1,339 · see citing works
Brugada, J., Katritsis, D. G., Arbelo, E., Arribas, F., Bax, J. J., Blomström‐Lundqvist, C., Calkins, H. G., Corrado, D., Deftereos, S. G., Diller, G., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz467 · Cited by 1,278 · see citing works
Tabacof, L., Tosto-Mancuso, J., Wood, J., Cortes, M., Kontorovich, A., McCarthy, D., Rizk, D., Rozanski, G., Breyman, E., Nasr, L., et al. (2021) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0000000000001910 · Cited by 493 · see citing works
Gluckman, T. J., Bhave, N. M., Allen, L. A., Chung, E. H., Spatz, E. S., Ammirati, E., Baggish, A. L., Bozkurt, B., Cornwell, W. K., Harmon, K. G., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.02.003 · Cited by 419 · see citing works
Self-citationAutonomic Nervous System Dysfunction
Goldberger, J. J., Arora, R., Buckley, U., & Shivkumar, K. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.12.064 · Cited by 355 · see citing works
Johansson, M., Ståhlberg, M., Runold, M., Nygren-Bonnier, M., Nilsson, J., Olshansky, B., Bruchfeld, J., & Fedorowski, A. (2021) · JACC: Case Reports · doi:10.1016/j.jaccas.2021.01.009 · Cited by 193 · see citing works
Proposed subtypes of post‐COVID‐19 syndrome (or long‐COVID) and their respective potential therapies
Yong, S. J., & Liu, S. (2021) · Reviews in Medical Virology · doi:10.1002/rmv.2315 · Cited by 165 · see citing works
Postural orthostatic tachycardia syndrome as a sequela of COVID-19
Ormiston, C. K., Świątkiewicz, I., & Taub, P. (2022) · Heart Rhythm · doi:10.1016/j.hrthm.2022.07.014 · Cited by 125 · see citing works
Post-Acute COVID-19 Syndrome and the cardiovascular system: What is known?
Dixit, N. M., Churchill, A., Nsair, A., & Hsu, J. J. (2021) · American Heart Journal Plus Cardiology Research and Practice · doi:10.1016/j.ahjo.2021.100025 · Cited by 129 · see citing works
Taub, P. R., Zadourian, A., Lo, H. C., Ormiston, C. K., Golshan, S., & Hsu, J. C. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.12.029 · Cited by 122 · see citing works
Gunning, W. T., Kvale, H. M., Kramer, P. M., Karabin, B. L., & Grubb, B. P. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.013602 · Cited by 118 · see citing works
COVID and Cardiovascular Disease: What We Know in 2021
Chilazi, M. J., Duffy, E. Y., Thakkar, A., & Michos, E. D. (2021) · Current Atherosclerosis Reports · doi:10.1007/s11883-021-00935-2 · Cited by 109 · see citing works
Postural Orthostatic Tachycardia Syndrome (POTS): A critical assessment
Olshansky, B., Cannom, D. S., Fedorowski, A., Stewart, J. M., Gibbons, C. H., Sutton, R., Shen, W.-K., Muldowney, J. A. S., Chung, T., Feigofsky, S., et al. (2020) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2020.03.010 · Cited by 102 · see citing works
Prospective Evaluation of Autonomic Dysfunction in Post-Acute Sequela of COVID-19
Jamal, S. M., Landers, D. B., Hollenberg, S. M., Turi, Z. G., Glotzer, T. V., Tancredi, J., & Parrillo, J. E. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.03.357 · Cited by 100 · see citing works
Post-Acute Sequelae of COVID-19 and Cardiovascular Autonomic Dysfunction: What Do We Know?
Bisaccia, G., Ricci, F., Recce, V., Serio, A., Iannetti, G., Chahal, A. A., Ståhlberg, M., Khanji, M. Y., Fedorowski, A., & Gallina, S. (2021) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd8110156 · Cited by 129 · see citing works
Long COVID-19 and Postural Orthostatic Tachycardia Syndrome- Is Dysautonomia to Be Blamed?
Chadda, K. R., Blakey, E. E., Huang, C. L.-H., & Jeevaratnam, K. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.860198 · Cited by 76 · see citing works
Bourne, K. M., Sheldon, R. S., Hall, J., Lloyd, M., Kogut, K., Sheikh, N., Jorge, J., Ng, J., Exner, D. V., Tyberg, J. V., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.040 · Cited by 76 · see citing works
Carmona-Torre, F., Mínguez‐Olaondo, A., López-Bravo, A., Tijero, B., Grozeva, V., Walcker, M., Azkune-Galparsoro, H., de Munaín, A. L., Alcaide, A. B., Quiroga, J. A., et al. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.886609 · Cited by 71 · see citing works
Malmö POTS symptom score: Assessing symptom burden in postural orthostatic tachycardia syndrome
Spahic, J. M., Hamrefors, V., Johansson, M., Ricci, F., Melander, O., Sutton, R., & Fedorowski, A. (2022) · Journal of Internal Medicine · doi:10.1111/joim.13566 · Cited by 69 · see citing works
Swai, J. D., Hu, Z., Zhao, X., Rugambwa, T. K., & Ming, G. (2019) · BMC Cardiovascular Disorders · doi:10.1186/s12872-019-01298-y · Cited by 65 · see citing works
A Case of Postural Orthostatic Tachycardia Syndrome Secondary to the Messenger RNA COVID-19 Vaccine
Reddy, S., Reddy, S., & Arora, M. (2021) · Cureus · doi:10.7759/cureus.14837 · Cited by 62 · see citing works
Noninvasive Vagus Nerve Stimulation in Postural Tachycardia Syndrome
Stavrakis, S., Chakraborty, P., Farhat, K., Whyte, S., Morris, L. M., Asad, Z. U. A., Karfonta, B., Anjum, J., Matlock, H. G., Cai, X., et al. (2023) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2023.10.015 · Cited by 63 · see citing works
Cardiovascular disease in space: A systematic review
Krittanawong, C., Isath, A. M., Kaplin, S. L., Virk, H. U. H., Fogg, S. E., Wang, Z., Shepanek, M. A., Scheuring, R. A., & Lavie, C. J. (2023) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2023.07.009 · Cited by 49 · see citing works
Mismatch between subjective and objective dysautonomia
Novák, P., Systrom, D. M., Marciano, S. P., Knief, A., Felsenstein, D., Giannetti, M. P., Hamilton, M. J., Nicoloro‐SantaBarbara, J. M., Saco, T. V., Castells, M., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-52368-x · Cited by 38 · see citing works
New insights into the pathogenesis of SARS-CoV-2 during and after the COVID-19 pandemic
Carvajal, J. J., García-Castillo, V., Cuellar, S. V., Campillay-Véliz, C. P., Salazar‐Ardiles, C., Avellaneda, A. M., Muñoz, C. A., Retamal-Díaz, A. R., Bueno, S. M., González, P. A., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1363572 · Cited by 39 · see citing works
Postural Orthostatic Tachycardia Syndrome (POTS): An Update for Clinical Practice.
Sebastian, S. A., Co, E. L., Panthangi, V., Jain, E., Ishak, A., Shah, Y., Vasavada, A., & Padda, I. (2022) · Current problems in cardiology · doi:10.1016/j.cpcardiol.2022.101384 · Cited by 33 · see citing works
Wang, Y., Zhang, C., Chen, S. Y., Liu, P., Wang, Y., Tang, C., Jin, H., & Du, J. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01214 · Cited by 33 · see citing works
Defining Cardiac Dysautonomia – Different Types, Overlap Syndromes; Case-based Presentations
Lakkireddy, D. (2020) · Journal of Atrial Fibrillation · doi:10.4022/jafib.2403 · Cited by 33 · see citing works
Disautonomia: Uma Condição Esquecida – Parte 1
Rocha, E. A., Mehta, N., Távora‐Mehta, M. Z. P., Roncari, C. F., Cidrão, A. A. D. L., & Elías, J. (2021) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20200420 · Cited by 40 · see citing works
Acute and Chronic Effects of COVID-19 on the Cardiovascular System
Arévalos, V., Ortega‐Paz, L., Rodríguez-Arias, J. J., Calvo-López, M., Golvano, L. C. C., Salazar-Rodríguez, A., Sabaté-Tormos, M., Spione, F., Sabaté, M., & Brugaletta, S. (2021) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd8100128 · Cited by 30 · see citing works
van Campen, C. M. C., & Visser, F. C. (2022) · Healthcare · doi:10.3390/healthcare10102058 · Cited by 30 · see citing works
Vernino, S. A., Hopkins, S., Bryarly, M. A., Hernandez, R. S., & Salter, A. R. (2024) · Clinical Autonomic Research · doi:10.1007/s10286-024-01020-9 · Cited by 28 · see citing works
Self-citationIvabradine in Postural Orthostatic Tachycardia Syndrome: A Review of the Literature
Tahir, F., Arif, T. B., Majid, Z., Ahmed, J., & Khalid, M. (2020) · Cureus · doi:10.7759/cureus.7868 · Cited by 28 · see citing works
Autonomic Dysfunction Related to Postacute SARS-CoV-2 Syndrome
Haloot, J., Bhavaraju-Sanka, R. K., Pillarisetti, J., & Verduzco‐Gutierrez, M. (2023) · Physical Medicine and Rehabilitation Clinics of North America · doi:10.1016/j.pmr.2023.04.003 · Cited by 28 · see citing works
Wells, R., Malik, V., Brooks, A. G., Linz, D., Elliott, A. D., Sanders, P., Page, A., Baumert, M., & Lau, D. H. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.017861 · Cited by 28 · see citing works
Dulal, D., Maraey, A. M., Elsharnoby, H. R., Chacko, P., & Grubb, B. P. (2025) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcae111 · Cited by 28 · see citing works
Maya, T. R., Fettig, V. M., Mehta, L., Gelb, B. D., & Kontorovich, A. (2021) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.62446 · Cited by 26 · see citing works
COVID-19 Vaccination Might Induce Postural Orthostatic Tachycardia Syndrome: A Case Report
Hermel, M. H., Sweeney, M., Abud, E., Luskin, K. T., Criado, J. P., Bonakdar, R. A., Gray, J., & AHERN, T. S. (2022) · Vaccines · doi:10.3390/vaccines10070991 · Cited by 23 · see citing works
Characteristics and Treatment of Exercise Intolerance in Patients With Long COVID
Edward, J. A., Peruri, A., Rudofker, E. W., Shamapant, N., Parker, H., Cotter, R., Sabin, K., Lawley, J. S., & Cornwell, W. K. (2023) · Journal of Cardiopulmonary Rehabilitation and Prevention · doi:10.1097/hcr.0000000000000821 · Cited by 24 · see citing works
Kell, D. B., Khan, A., Kane, B., Lip, G. Y. H., & Pretorius, E. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14020170 · Cited by 23 · see citing works
Wang, S. Y., Adejumo, P., See, C., Onuma, O. K., Miller, E. J., & Spatz, E. S. (2022) · American Heart Journal Plus Cardiology Research and Practice · doi:10.1016/j.ahjo.2022.100176 · Cited by 20 · see citing works
Ongoing Dizziness Following Acute COVID-19 Infection: A Single Center Pediatric Case Series
Drogalis-Kim, D. E., Kramer, C., & Duran, S. R. (2022) · PEDIATRICS · doi:10.1542/peds.2022-056860 · Cited by 19 · see citing works
Bozkurt, B., Das, S. R., Addison, D., Gupta, A., Jneid, H. M., Khan, S. S., Koromia, G. A., Kulkarni, P. A., LaPoint, K., Lewis, E. F., et al. (2022) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/hcq.0000000000000111 · Cited by 20 · see citing works
Farley, M., Estrada-Mendizábal, R. J., Gansert, E. A., Voelker, D., Marks, L. A., & Gonzalez‐Estrada, A. (2025) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2025.03.022 · Cited by 18 · see citing works
Zhang, Q., Xu, B., & Du, J. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00525 · Cited by 18 · see citing works
Cai, H., Wang, S., Zou, R., Wang, Y., & Wang, C. (2020) · Autonomic Neuroscience · doi:10.1016/j.autneu.2020.102715 · Cited by 17 · see citing works
Autoimmune autonomic ganglionopathy: Ganglionic acetylcholine receptor autoantibodies.
Urriola, N., & Adelstein, S. (2021) · Autoimmunity Reviews · doi:10.1016/j.autrev.2021.102988 · Cited by 18 · see citing works
Postural orthostatic tachycardia syndrome after COVID-19 vaccination
Teodorescu, D. L., Kote, A., Reaso, J. N., Rosenberg, C., Liu, X., Kwan, A. C., Cheng, S. C., & Chen, P. (2023) · Heart Rhythm · doi:10.1016/j.hrthm.2023.09.012 · Cited by 17 · see citing works
Cornwell, W. K., Levine, B. D., Baptiste, D., Bhave, N. M., Desai, S., Dineen, E. H., Durstenfeld, M. S., Edward, J. A., Huang, M., Jacobsen, R. M., et al. (2025) · Circulation · doi:10.1161/cir.0000000000001348 · Cited by 17 · see citing works
Self-citationDysautonomia and Headache in the Pediatric Population
Wig, R., & Oakley, C. B. (2019) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13659 · Cited by 16 · see citing works
Bozkurt, B., Das, S. R., Addison, D., Gupta, A., Jneid, H. M., Khan, S. S., Koromia, G. A., Kulkarni, P. A., LaPoint, K., Lewis, E. F., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.03.355 · Cited by 16 · see citing works
Ganglionic Acetylcholine Receptor Antibodies in Postural Tachycardia Syndrome
Bryarly, M. A., Raj, S. R., Phillips, L. T., Hynan, L. S., Okamoto, L. E., Arnold, A. C., Paranjape, S. Y., Vernino, M., Black, B. K., & Vernino, S. A. (2021) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000001047 · Cited by 16 · see citing works
Self-citationSmith, E. C., Diedrich, A., Raj, S. R., Gamboa, A., Shibao, C. A., Black, B. K., Peltier, A., Paranjape, S. Y., Biaggioni, I., & Okamoto, L. E. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.016196 · Cited by 16 · see citing works
Varanasi, S., Sathyamoorthy, M., Chamakura, S. R., & Shah, S. A. (2021) · Cureus · doi:10.7759/cureus.18398 · Cited by 12 · see citing works
Autonomic neuropathy as post-acute sequela of SARS-CoV-2 infection: a case report
Agnihotri, S., Luis, C. V. S., & Kazamel, M. (2022) · Journal of NeuroVirology · doi:10.1007/s13365-022-01056-5 · Cited by 14 · see citing works
What has cardiac rehabilitation looked like in the COVID-19 pandemic: Lessons learned for the future
Ozemek, C., Berry, R., Bonikowske, A. R., German, C. A., & Gavic, A. M. (2023) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2023.01.001 · Cited by 12 · see citing works
Ocher, R., Padilla, E., Hsu, J. C., & Taub, P. R. (2021) · Case Reports in Cardiology · doi:10.1155/2021/7809231 · Cited by 14 · see citing works
Hyperadrenergic Postural Tachycardia Syndrome: Clinical Biomarkers and Response to Guanfacine
Okamoto, L. E., Urechie, V., Rigo, S., Abner, J. J., Giesecke, M., Muldowney, J. A. S., Furlan, R., Shibao, C. A., Shirey-Rice, J. K., Pulley, J. M., et al. (2024) · Hypertension · doi:10.1161/hypertensionaha.124.23035 · Cited by 13 · see citing works
Orthostatic intolerance in post-concussion patients
Gould, S. J., Cochrane, G. D., Johnson, J., Hebson, C. L., & Kazamel, M. (2021) · The Physician and Sportsmedicine · doi:10.1080/00913847.2021.1953357 · Cited by 13 · see citing works
Postural orthostatic tachycardia syndrome and post-acute COVID-19
Amekran, Y., Damoun, N., & Hangouche, A. J. E. (2022) · Global Cardiology Science and Practice · doi:10.21542/gcsp.2022.13 · Cited by 15 · see citing works
Postural orthostatic tachycardia syndrome: pathophysiology, management, and experimental therapies
Narasimhan, B., Aggarwal, D., Satish, P., Kantharia, B. K., & Aronow, W. S. (2022) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2022.2121697 · Cited by 12 · see citing works
Sanada, Y., Azuma, J., Hirano, Y., Hasegawa, Y., & Yamamoto, T. (2022) · Cureus · doi:10.7759/cureus.31006 · Cited by 12 · see citing works
Autoimmunity and postural orthostatic tachycardia syndrome: Implications in diagnosis and management
Aboseif, A., Bireley, J. D., Li, Y., Polston, D. W., & Abbatemarco, J. (2023) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.90a.22093 · Cited by 12 · see citing works
Ivabradine in children with postural orthostatic tachycardia syndrome: a retrospective study
Towheed, A., Nesheiwat, Z., Mangi, M. A., Karabin, B. L., & Grubb, B. P. (2020) · Cardiology in the Young · doi:10.1017/s1047951120001341 · Cited by 12 · see citing works
Kesserwani, H. N. (2020) · Cureus · doi:10.7759/cureus.10881 · Cited by 12 · see citing works
Return to Activity After SARS-CoV-2 Infection: Cardiac Clearance for Children and Adolescents
Chowdhury, D., Fremed, M. A., Dean, P. N., Glickstein, J. S., Robinson, J. A., Rellosa, N., Thacker, D., Soma, D. B., Briskin, S. M., Asplund, C. A., et al. (2021) · Sports Health A Multidisciplinary Approach · doi:10.1177/19417381211039746 · Cited by 12 · see citing works
Children With PANS May Manifest POTS
Chan, A. L., Gao, J., Houston, M., Willett, T. A., Farhadian, B., Silverman, M. A., Tran, P., Jaradeh, S. S., Thienemann, M., & Frankovich, J. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.819636 · Cited by 13 · see citing works
Management of orthostatic intolerance in children: the state of the art
Tao, C., Jin, H., & Du, J. (2020) · World Journal of Pediatrics · doi:10.1007/s12519-019-00329-0 · Cited by 11 · see citing works
Non-invasive Vagus Nerve Simulation in Postural Orthostatic Tachycardia Syndrome
Chakraborty, P., Farhat, K., Morris, L. M., Whyte, S., Yu, X., & Stavrakis, S. (2023) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2023.20 · Cited by 11 · see citing works
Tanking, C., Lakkananurak, C., Srisakvarakul, C., Jitpreeda, A., Threechod, K., & Sukitpunyaroj, D. (2024) · Journal of Arrhythmia · doi:10.1002/joa3.13001 · Cited by 11 · see citing works
Moak, J. P., Ramwell, C. B., Gordish‐Dressman, H., Sule, S., & Bettini, E. (2024) · Autonomic Neuroscience · doi:10.1016/j.autneu.2024.103163 · Cited by 11 · see citing works
Pearson, R., Sheridan, C. A., Kang, K., Brown, A., Baham, M., Asarnow, R. F., Giza, C. C., & Choe, M. C. (2022) · Child Neurology Open · doi:10.1177/2329048x221082753 · Cited by 11 · see citing works
Postural Orthostatic Tachycardia Syndrome and Orthostatic Hypotension Post COVID-19
Shahmohamadi, E., Eslami, M., Mollazadeh, R., Mirshafiee, S., Sehat, P., Alizadeh, F., Emkanjoo, Z., & Far, V. L. (2022) · Infectious Disorders - Drug Targets · doi:10.2174/1871526522666220610143504 · Cited by 11 · see citing works
Spera, F. R., Mistrulli, R., Salerno, L., Vannini, F., Muthukkattil, M. L., Falcetti, R., Segal, T. Y., Barbato, E., & Buonsenso, D. (2024) · Current Clinical Microbiology Reports · doi:10.1007/s40588-024-00217-w · Cited by 11 · see citing works
Postural Orthostatic Tachycardia Syndrome
Zhao, S. Z., & Tran, V. H. (2020) · StatPearls · Cited by 11 · see citing works
Yaxley, K. L. (2020) · SAGE Open Medical Case Reports · doi:10.1177/2050313x20915413 · Cited by 11 · see citing works
Pierson, B. C., Apilado, K. P., Franzos, M. A., Allard, R. J., Mancuso, J. D., Tribble, D. R., Saunders, D., & Koehlmoos, T. P. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2024.1515486 · Cited by 10 · see citing works
Xu, B., Zhang, Q., Li, X., Tang, C., Du, J., Liu, X., & Jin, H. (2023) · World Journal of Pediatrics · doi:10.1007/s12519-022-00677-4 · Cited by 10 · see citing works
Pietri-Toro, J., Gardner, O. K., Leuchter, J. D., DiBartolomeo, G., Hunter, J. A., & Forghani, I. (2023) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.63168 · Cited by 10 · see citing works
Tran, V. P., Tran, T. T., Hao, H. T., Hau, N. T. H., Jain, N., & Reinis, A. (2023) · Human Antibodies · doi:10.3233/hab-220013 · Cited by 10 · see citing works
Svensson, A., Svensson‐Raskh, A., Holmström, L., Hallberg, C., Bezuidenhout, L., Conradsson, D. M., Ståhlberg, M., Bruchfeld, J., Fedorowski, A., & Nygren‐Bonnier, M. (2024) · Scientific Reports · doi:10.1038/s41598-024-71055-5 · Cited by 11 · see citing works
Ivabradine and AF: Coincidence, Correlation or a New Treatment?
Abdelnabi, M. H., Ahmed, A. U., Almaghraby, A. M., Saleh, Y., & Badran, H. (2020) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2019.30.2 · Cited by 11 · see citing works
Postural orthostatic tachycardia syndrome: A conundrum for patients and healthcare providers.
Cline, H. M., & Einhardt, A. (2022) · PubMed Central · doi:10.1097/01.npr.0000802968.90212.70 · Cited by 2 · see citing works
Levine, B. D., Nicol, E. D., & Davos, C. H. (2022) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwac125 · Cited by 10 · see citing works
Self-citationSteinberg, R. S., Dicken, W., & Cutchins, A. C. (2023) · US Cardiology Review · doi:10.15420/usc.2022.35 · Cited by 9 · see citing works
McGregor, G., Hee, S. W., Eftekhari, H., Holliday, N., Pearce, G., Sandhu, H. K., Simmonds, J. V., Joshi, S., Kavi, L., Bruce, J., et al. (2020) · Pilot and Feasibility Studies · doi:10.1186/s40814-020-00702-1 · Cited by 10 · see citing works
Guo, Y., Li, H., Deng, J., Zhang, G., Fischer, H., Stavrakis, S., & Yu, X. (2022) · Heart Rhythm O2 · doi:10.1016/j.hroo.2022.12.001 · Cited by 9 · see citing works
Evidence for Impaired Renin Activity in Postural Orthostatic Tachycardia Syndrome
Spahic, J. M., Mattisson, I. Y., Hamrefors, V., Johansson, M., Ricci, F., Nilsson, J. Å., Melander, O., Sutton, R., & Fedorowski, A. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12144660 · Cited by 8 · see citing works
Peebles, K. C., Jacobs, C., Makaroff, L., & Pacey, V. (2024) · Autonomic Neuroscience · doi:10.1016/j.autneu.2024.103156 · Cited by 8 · see citing works
Faintly tired: a systematic review of fatigue in patients with orthostatic syncope
Wu, R. E. Y., Khan, F. M., Hockin, B. C. D., Lobban, T., Sanatani, S., & Claydon, V. E. (2022) · Clinical Autonomic Research · doi:10.1007/s10286-022-00868-z · Cited by 8 · see citing works
Putrino, D. F., TABACOF, L. R., Tosto-Mancuso, J. M., Wood, J., Cortes, M., Kontorovich, A., McCarthy, D., Breyman, E., Nasr, L., Neglia, A., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-440909/v1 · Cited by 8 · see citing works
Postural Orthostatic Tachycardia Syndrome Associated with COVID-19: A Narrative Review
Park, J.-H., Park, S., Kim, N.-H., Lee, Y., Chang, Y., & Song, T.-J. (2024) · Medicina · doi:10.3390/medicina60081325 · Cited by 9 · see citing works
Harris, C. I. (2022) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2022.06.002 · Cited by 7 · see citing works
Postural Orthostatic Tachycardia Syndrome (POTS): A Frequently Missed Diagnosis
George, A., & Winters, B. A. (2022) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2022.08.022 · Cited by 7 · see citing works
Differential diagnosis of vasovagal syncope and postural tachycardia syndrome in children
Wang, Y., Du, J., & Jin, H. (2020) · World Journal of Pediatrics · doi:10.1007/s12519-019-00333-4 · Cited by 7 · see citing works
Wang, Z., Zhu, T., Li, X., Lai, X., & Chen, M. (2025) · Clinical Cardiology · doi:10.1002/clc.70110 · Cited by 6 · see citing works
Characterization of Postural Orthostatic Tachycardia Syndrome in Long COVID
Mouslmani, M. A., Sawano, M., Arun, A. S., Wu, Y., Shah, R. M., Kaleem, S., Zhou, T., Murugiah, K., Lu, Y., Herrin, J. S., et al. (2025) · JACC Advances · doi:10.1016/j.jacadv.2025.101873 · Cited by 6 · see citing works
Xu, B., Gao, Y., Zhang, Q., Li, X., Liu, X., Du, J., & Jin, H. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2023.104951 · Cited by 6 · see citing works
Marchetta, M., Lopez, R. I., Hogwood, A. C., Thomas, G., Abbate, G., Markley, R., Canada, J. M., & Abbate, A. (2025) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001705 · Cited by 6 · see citing works
Postural Orthostatic Tachycardia Syndrome as a Manifestation of Post-COVID-19 Syndrome
Trisvetova, E. L. (2022) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2022-04-11 · Cited by 8 · see citing works
- Authors
- Bryarly, M., Phillips, L. T., Fu, Q., Vernino, S., & Levine, B. D.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Texas Health Dallas (US)
- Corresponding author
- Levine, Benjamin D.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2019-03
- Volume
- 73
- Issue
- 10
- Pages
- 1207-1228
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2921285569
- Semantic Scholar
- 740ef6a8cee1d3f390f8ab74aa520e3c99885859
- Cited by
- 245
- References
- 116
- Citations by year
- 2026: 34 · 2025: 38 · 2024: 38 · 2023: 28 · 2022: 41 · 2021: 34 · 2020: 26 · 2019: 6
- FWCI
- 5.51
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of the American College of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Biogen
- H. Lundbeck A/S
- National Institutes of Health
- National Heart, Lung, and Blood Institute (K23HL075283)
- National Center for Research Resources (M01RR000633)
- Topics
- Health Sciences › Medicine › Surgery › Cardiovascular Syncope and Autonomic Disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
- Health Sciences › Medicine › Neurology › Long-Term Effects of COVID-19
- Keywords
- postural orthostatic tachycardia syndrome, orthostatic intolerance, pathophysiology, comorbidities, differential diagnosis, evaluation, treatment, young women, autonomic dysfunction
- MeSH terms
- Diagnosis, Differential, Humans, Patient Care Management, Comorbidity, Causality, Postural Orthostatic Tachycardia Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-31.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-31.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review